<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Continuation and maintenance treatments for depression in older people - Wilkinson, P - 2016 | Cochrane Library</title> <meta content="Continuation and maintenance treatments for depression in older people - Wilkinson, P - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006727.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Continuation and maintenance treatments for depression in older people - Wilkinson, P - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006727.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006727.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Continuation and maintenance treatments for depression in older people" name="citation_title"/> <meta content="Philip Wilkinson" name="citation_author"/> <meta content="philip.wilkinson@psych.ox.ac.uk" name="citation_author_email"/> <meta content="Zehanah Izmeth" name="citation_author"/> <meta content="John Radcliffe Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD006727.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/09/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006727.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006727.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006727.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antidepressive Agents [*therapeutic use]; Combined Modality Therapy [methods]; Depression [*therapy]; Maintenance Chemotherapy [methods]; Psychotherapy [*methods]; Randomized Controlled Trials as Topic; Secondary Prevention" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006727.pub3&amp;doi=10.1002/14651858.CD006727.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006727\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006727\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","hr","fr","pl","zh_HANS","fa","ja","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006727.pub3",title:"Continuation and maintenance treatments for depression in older people",firstPublishedDate:"Sep 9, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006727.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006727.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006727.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006727.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006727.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006727.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006727.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006727.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006727.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006727.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7214 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006727.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0216"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0087"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-sec-0199"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/appendices#CD006727-sec-0221"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/table_n/CD006727StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/table_n/CD006727StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Continuation and maintenance treatments for depression in older people</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information#CD006727-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Philip Wilkinson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information#CD006727-cr-0003">Zehanah Izmeth</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information/en#CD006727-sec-0238">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 September 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006727.pub3">https://doi.org/10.1002/14651858.CD006727.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006727-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006727-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006727-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006727-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006727-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006727-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006727-abs-0001" lang="en"> <section id="CD006727-sec-0001"> <h3 class="title" id="CD006727-sec-0001">Background</h3> <p>Depressive illness is common in old age. Prevalence in the community of case level depression is around 15% and milder forms of depression are more common. It causes significant distress and disability. The number of people over the age of 60 years is expected to double by 2050 and so interventions for this often long‐term and recurrent condition are increasingly important. The causes of late‐life depression differ from depression in younger adults and so it is appropriate to study it separately. </p> <p>This is an update of a Cochrane review first published in 2012.</p> </section> <section id="CD006727-sec-0002"> <h3 class="title" id="CD006727-sec-0002">Objectives</h3> <p>To examine the efficacy of antidepressants and psychological therapies in preventing the relapse and recurrence of depression in older people. </p> </section> <section id="CD006727-sec-0003"> <h3 class="title" id="CD006727-sec-0003">Search methods</h3> <p>We performed a search of the Cochrane Common Mental Disorders Group's specialised register (the CCMDCTR) to 13 July 2015. The CCMDCTR includes relevant randomised controlled trials (RCTs) from the following bibliographic databases: <i>The Cochrane Library</i> (all years), MEDLINE (1950 to date), EMBASE (1974 to date), and PsycINFO (1967 to date). We also conducted a cited reference search on 13 July 2015 of the Web of Science for citations of primary reports of included studies. </p> </section> <section id="CD006727-sec-0004"> <h3 class="title" id="CD006727-sec-0004">Selection criteria</h3> <p>Both review authors independently selected studies. We included RCTs involving people aged 60 years and over successfully treated for an episode of depression and randomised to receive continuation and maintenance treatment with antidepressants, psychological therapies, or a combination. </p> </section> <section id="CD006727-sec-0005"> <h3 class="title" id="CD006727-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data. The primary outcome for benefit was recurrence rate of depression (reaching a cut‐off on any depression rating scale) at 12 months and the primary outcome for harm was drop‐outs at 12 months. Secondary outcomes included relapse/recurrence rates at other time points, global impression of change, social functioning, and deaths. We performed meta‐analysis using risk ratio (RR) for dichotomous outcomes and mean difference (MD) for continuous outcomes, with 95% confidence intervals (CI). </p> </section> <section id="CD006727-sec-0006"> <h3 class="title" id="CD006727-sec-0006">Main results</h3> <p>This update identified no further trials. Seven studies from the previous review met the inclusion criteria (803 participants). Six compared antidepressant medication with placebo; two involved psychological therapies. There was marked heterogeneity between the studies. </p> <p>Comparing antidepressants with placebo on the primary outcome for benefit, there was a statistically significant difference favouring antidepressants in reducing recurrence compared with placebo at 12 months with a GRADE rating of low for quality of evidence (three RCTs, n = 247, RR 0.67, 95% CI 0.54 to 0.82; number needed to treat for an additional beneficial outcome (NNTB) 5). Comparing antidepressants with placebo on the primary outcome for harms, there was no difference in drop‐out rates at 12 months' follow‐up, with a GRADE rating of low. </p> <p>There was no significant difference between psychological treatment and antidepressant in recurrence rates at 12 months (one RCT, n = 53) or between combination treatment and antidepressant alone at 12 months. </p> </section> <section id="CD006727-sec-0007"> <h3 class="title" id="CD006727-sec-0007">Authors' conclusions</h3> <p>This updated Cochrane review supports the findings of the original 2012 review. The long‐term benefits and harm of continuing antidepressant medication in the prevention of recurrence of depression in older people are not clear and no firm treatment recommendations can be made on the basis of this review. Continuing antidepressant medication for 12 months appears to be helpful with no increased harms; however, this was based on only three small studies, relatively few participants, use of a range of antidepressant classes, and clinically heterogeneous populations. Comparisons at other time points did not reach statistical significance. </p> <p>Data on psychological therapies and combined treatments were too limited to draw any conclusions on benefits and harms. </p> <p>The quality of the evidence used in reaching these conclusions was low and the review does not, therefore, offer clear guidance to clinicians and patients on best practice and matching interventions to particular patient characteristics. </p> <p>Of note, we identified no new studies that evaluated pharmacological or psychological interventions in the continuation and maintenance treatment of depression in older people. We are aware of studies conducted since the previous review that included both older people and adults under the age of 65 years, but these fall outside of the remit of this review. We believe that there remains a need for studies solely recruiting older people, particularly the 'older old' with comorbid medical problems. However, these studies are likely to be challenging to conduct and may not, so far, have been prioritised by funders. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006727-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006727-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006727-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006727-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006727-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD006727-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006727-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006727-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD006727-abs-0008">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006727-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006727-abs-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006727-abs-0016">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006727-abs-0003" lang="en"> <h3>Long‐term treatment for depression in older people</h3> <p>This is an update of a Cochrane review first published in 2012.</p> <p><b>Why is this review important?</b> </p> <p>Depression is a common problem among older people and causes considerable disability. Even after successful treatment, it frequently recurs. </p> <p>The causes of depression in older people are more diverse than in younger adults and, as the number of older people is steadily increasing, it is important to study the effects of treatments specifically in older adults. Treatments commonly used are antidepressant drugs and psychological treatments (talking treatments). </p> <p><b>Who will be interested in this review?</b> </p> <p>‐ People with depression, friends, families, and carers.</p> <p>‐ General practitioners, psychiatrists, clinical psychologists, psychological therapists, and pharmacists. </p> <p>‐ Professionals working in older‐adult mental health services.</p> <p>‐ Professionals working in Improving Access to Psychological Therapies services in the UK. </p> <p><b>What questions does this review aim to answer?</b> </p> <p>In people aged 60 years and over who have recovered from depression while taking antidepressant medication: </p> <p>‐ Is receiving continued antidepressant medicine, psychological treatment, or a combination of the two more effective in preventing recurrence of depression than receiving placebo (a pretend treatment) or any of the other treatments? </p> <p>‐ Is receiving continued antidepressant medicine, psychological treatment, or a combination of the two more harmful than receiving placebo or any of the other treatments? </p> <p><b>Which studies does the review include?</b> </p> <p>We searched medical databases to find all relevant studies completed up to 13 July 2015. The studies had to compare antidepressant treatment, psychological treatment, or a combination of the two, with placebo or the other treatments for preventing recurrence of depression in people aged 60 years and over. We included seven studies, involving 803 people. </p> <p>Six studies compared antidepressant medicine with placebo. Only two of the studies involved psychological treatments. The studies varied in how they were conducted, numbers of participants, and types of participants. </p> <p><b>What does the evidence from the review tell us?</b> </p> <p>Remaining on antidepressant medicines for one year appears to reduce the risk of depression returning from 61% to 42% but the benefits at other time intervals could not be determined. Antidepressant treatment appeared to be no more harmful than placebo as measured by number of participants dropping out of trials. The benefits of psychological therapies were not clear, due to the small number of studies. The quality of evidence was low. </p> <p>The majority of participants in the studies were women. Few were over 75 years of age. Most had received treatment for their original depressive illness as outpatients, indicating less severe depression. </p> <p>Antidepressant medicines used were both older type antidepressants (called tricyclics) and newer type (called selective serotonin reuptake inhibitors). Psychological treatments were interpersonal therapy, which addresses obstacles in relationships, and cognitive behavioural therapy, which addresses inactivity and self‐defeating thought patterns. </p> <p><b>What should happen next?</b> </p> <p>This review provides limited evidence that continuing antidepressant medication for one year can reduce the risk of depression recurring with no additional harm. However, it cannot be used to make firm recommendations due to the limited number and small size of studies involved. Limitations in the design and reporting of these studies may also make the results unrepresentative. Similarly, no firm conclusions can be drawn about psychological treatments or combinations of antidepressant and psychological treatments in preventing recurrence. </p> <p>Further, larger, trials are required to clarify any benefits of antidepressant and psychological treatments. These trials should include more people aged over 75, and people with other problems typical of people treated in routine clinical services, such long‐term physical illness and mild memory problems. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006727-sec-0216" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006727-sec-0216"></div> <h3 class="title" id="CD006727-sec-0217">Implications for practice</h3> <section id="CD006727-sec-0217"> <p>As far as the review authors are aware, this is the first systematic review of both antidepressants and psychological therapies in the prevention of recurrence of depression in people aged 60 years and over who have recovered from a depressive illness while taking antidepressant medication. Although there was a significant reduction in recurrence rates in three trials comparing selective serotonin reuptake inhibitors or tricyclic antidepressants with placebo medication at 12 months' follow‐up, the meta‐analysis was relatively underpowered due to small sample sizes; analyses at other time points did not reach statistical significance. In addition, the quality of this evidence was low as assessed with the GRADE guideline development tool. Therefore, on the basis of this review, we can make no firm recommendations on the optimum period of antidepressant maintenance treatment with older adults. Therefore, the best evidence to date comes from trials with adults of all ages (<a href="./references#CD006727-bbs2-0043" title="National Institute for Health and Care Excellence. The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90, 2010. www.nice.org.uk/Guidance/cg90 (accessed 8 August 2016). ">NICE 2010</a>), which is to continue treatment for at least six months, or for two years or longer if there is a known high likelihood of recurrence or significant clinical risks. As trials reported significant numbers of drop‐outs, it is possible that the benefit of treatment is greater in people remaining on antidepressant medication. There was no difference in treatment acceptability (as measured by overall drop‐outs and drop‐outs due to adverse effects) or death rates between antidepressant and placebo. </p> <p>There was no significant overall benefit for antidepressant treatment at 24 months' follow‐up in four trials with 282 participants, but when we combined data from the three trials of tricyclic antidepressant medication (169 participants), there was a significant reduction in recurrence (number needed to treat for an additional beneficial outcome (NNTB) = 5). In the one trial that followed up participants taking a tricyclic antidepressant for 36 months, there was evidence of benefit of treatment compared with placebo (NNTB = 4). Thus, it is possible that tricyclic antidepressants have significant longer‐term benefits (two to three years) in the prevention of recurrence of depression. </p> <p>On the basis of this review, it is not possible to make recommendations on the characteristics of people most likely to benefit from long‐term antidepressant treatment. </p> <p>There were only two small trials of psychological therapies in the review and we can make no firm recommendations on the use of psychological therapies in the prevention of recurrence in older adults. Therefore, the best evidence to date comes from trials with adults of all ages (<a href="./references#CD006727-bbs2-0043" title="National Institute for Health and Care Excellence. The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90, 2010. www.nice.org.uk/Guidance/cg90 (accessed 8 August 2016). ">NICE 2010</a>), which is to consider cognitive behavioural therapy or mindfulness‐based cognitive therapy if depression is recurrent. It is possible that in 'younger old' adults (aged 60 to 70 years) without significant physical health problems or cognitive impairment, IPT may be as efficacious as tricyclic antidepressant at preventing recurrence for up to three years. </p> <p>The effects of combining psychological therapies with antidepressant are also unclear. Combined data from the two trials showed no significant benefit of combination compared with antidepressant therapy alone. In one trial, psychological therapies appeared as effective as combined treatment at 12 months' follow‐up, but not in longer‐term follow‐up. </p> </section> <h3 class="title" id="CD006727-sec-0218">Implications for research</h3> <section id="CD006727-sec-0218"> <p>This review included only a small number of trials with small numbers of participants. Larger trials are needed to confirm the longer‐term benefits of antidepressant medication in older people.  A direct comparison of selective serotonin reuptake inhibitors with tricyclic antidepressants would determine whether tricyclic antidepressants are superior and equally acceptable in older people; this might include both low‐ and high‐dose tricyclic antidepressant arms as there is a trade‐off between clinical benefits and adverse effects with this class of antidepressant (<a href="./references#CD006727-bbs2-0008" title="ReynoldsCFIII , PerelJM , FrankE , CornesC , MillerMD , HouckPR , et al. Three‐year outcomes of maintenance nortriptyline treatment in late‐life depression: a study of two fixed plasma levels. American Journal of Psychiatry1999;156(8):1177‐81. ">Reynolds 1999b</a>). </p> <p>Despite the apparent benefit of maintaining antidepressant treatment, one‐year recurrence rates in people remaining on treatment are high (around 50% in this review). Thus, it is important that future research identifies additional strategies that might improve outcomes. This research should include further, larger trials of a broader range of interventions, including psychological therapies. In one study by <a href="./references#CD006727-bbs2-0047" title="ReynoldsCF3rd , ButtersMA , LopezO , PollockBG , DewMA , MulsantBH , et al. Maintenance treatment of depression in old age. A randomized, double‐blind, placebo‐controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Archives of General Psychiatry2011;68(1):51‐60. ">Reynolds 2011</a>, the addition of the cholinesterase inhibitor donepezil to maintenance antidepressant medication did not further reduce recurrence rate. </p> <p>Trial participants in this review were mainly the ‘younger old’ and physically well. A further study with participants aged 70 years and over demonstrated benefit from antidepressant medication but a poorer response to interpersonal psychological therapies (<a href="./references#CD006727-bbs2-0009" title="CarreiraK , MillerMD , FrankE , HouckPR , MorseJQ , DewMA , et al. A controlled evaluation of monthly maintenance Interpersonal psychotherapy in late‐life depression with varying levels of cognitive function. International Journal of Geriatric Psychiatry2008;23:1110‐3. DombrovskiAY , LenzeEJ , DewMA , MulsantBH , PollockBG , HouckPR , et al. Maintenance treatment for old‐age depression preserves health‐related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Journal of the American Geriatrics Society2007;55(9):1325‐32. ReynoldsCF , DewMA , PollockBG , MulsantBH , FrankE , MillerMD , et al. Maintenance treatment of major depression in old age. New England Journal of Medicine2006;354:1130‐8. ">Reynolds 2006</a>, excluded from this review). Some large and important studies addressing maintenance treatments do include older adults in among adults of all ages. For instance, a study of mindfulness‐based cognitive therapy published since the original review included participants up to 79 years of age but without separate analysis of data from older participants (<a href="./references#CD006727-bbs2-0035" title="KuykenW , HayesR , BarrettB , ByngR , DalgleishT , KesslerD , et al. Effectiveness and cost‐effectiveness of mindfulness‐based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet2015;386 (9988):63‐73. ">Kuyken 2015</a>). We believe that it is important that future trials of maintenance treatments in late‐life depression, both with antidepressants and psychological therapies, are conducted solely with populations of participants representative of older adults increasingly encountered in routine clinic practice, that is, over 70 years of age, experiencing mild‐to‐moderate cognitive impairment, and with comorbid physical illnesses. This would properly address the impact of age‐related clinical factors on response to different treatment modalities. It is also important to understand the precise role of neuropsychological deficits in late‐life depression better and the extent to which they are reversed by treatment (<a href="./references#CD006727-bbs2-0034" title="KorsnesMS , UlsteinID . Cognitive effects of late life depression: review of neuropsychological findings. Journal of Behavioral and Brain Science2015;4:141‐57. ">Korsnes 2015</a>). </p> <p>Future studies should examine the reasons for drop‐out and include quality of life measures and cost‐effectiveness analysis. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006727-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006727-sec-0036"></div> <div class="table" id="CD006727-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antidepressant medication compared with placebo at 12 months' follow‐up</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Antidepressant medication compared with placebo at 12 months' follow‐up</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> older people in remission from depression<br/> <b>Setting:</b> mixed<br/> <b>Intervention:</b> antidepressant<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antidepressant</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Recurrence at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.67<br/> (0.55 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>247<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2 trials used TCAs (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>); 1 used an SSRI (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). Trials varied in setting, mean age, cut‐off for remission, and length of remission before randomisation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>730 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>489 per 1000<br/> (402 to 599) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>759 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>508 per 1000<br/> (417 to 622) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Overall drop‐out rates (excluding deaths) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.48<br/> (0.75 to 2.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>121<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Only 1 trial reporting drop‐outs at 12 months (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). <a href="./references#CD006727-bbs2-0008" title="ReynoldsCFIII , PerelJM , FrankE , CornesC , MillerMD , HouckPR , et al. Three‐year outcomes of maintenance nortriptyline treatment in late‐life depression: a study of two fixed plasma levels. American Journal of Psychiatry1999;156(8):1177‐81. ">Reynolds 1999b</a> reported drop‐outs but not timing </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>267 per 1000<br/> (135 to 527) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>267 per 1000<br/> (135 to 526) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SSRI:</b> selective serotonin reuptake inhibitor; <b>TCA:</b> tricyclic antidepressant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Downgraded one point for imprecision (only three studies) and one point for risk of bias since allocation concealment and blinding were unclear for two of the studies and study protocols were not available for all three studies. </p> <p>2. Downgraded two points due to imprecision (only one study; wide confidence intervals).</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006727-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006727-sec-0037"></div> <section id="CD006727-sec-0038"> <h3 class="title" id="CD006727-sec-0038">Description of the condition</h3> <p>Depression is among the most common of psychiatric disorders. It remains common in old age, occurring more frequently than dementia. Several community studies have shown a prevalence in the population over 64 years of age of around 15% of case level depression (i.e. that which a psychiatrist would consider in need of treatment) (<a href="./references#CD006727-bbs2-0019" title="EvansO , SingletonN , MeltzerH , StewartR , PinceM . The mental health of older people. The mental health of older people. London: HMSO, 2003. ">Evans 2003</a>). Milder forms of depression are likely to be more common and still account for significant suffering. Very old people are particularly prone to developing depression (<a href="./references#CD006727-bbs2-0016" title="BlazerD . Psychiatry and the oldest old. American Journal of Psychiatry2000;157:1915‐24. ">Blazer 2000</a>). </p> <p>Depression is important because it causes significant distress and is associated with a great deal of disability in older people. Chronic depression is associated with over five times the odds of worsening disability over three years (<a href="./references#CD006727-bbs2-0036" title="LenzeEJ , SchulzR , MartireLM , ZdaniukB , GlassT , KopWJ , et al. The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal survey from the Cardiovascular Health Study. Journal of the American Geriatrics Society2005;53(4):569. ">Lenze 2005</a>). The number of people over the age of 60 years is expected to double by 2050 and so interventions for long‐term and recurrent conditions such as depression will become more important in maintaining healthy functioning (<a href="./references#CD006727-bbs2-0054" title="World Health Organization. World Report on Ageing and Health, 2015. Geneva: World Health Organization. ">WHO 2015</a>). </p> <p>The causes of late‐life depression, especially in cases with onset after 50 years of age, are thought to differ from depression in younger adults. They include neuropsychological abnormalities such as executive dysfunction (<a href="./references#CD006727-bbs2-0024" title="GanslerDA , SuvakM , AreanP , AlexopoulosGS . Role of executive dysfunction and dysexecutive behaviour in late‐life depression and disability. American Journal of Geriatric Psychiatry2015;23(10):1038‐45. ">Gansler 2015</a>), and physical illnesses such as cardiovascular disease, diabetes, and stroke (<a href="./references#CD006727-bbs2-0050" title="ValkanovaV , EbmeierKP . Vascular risk factors and depression in later life: a systematic review and meta‐analysis. Biological Psychiatry2013;73:406‐13. ">Valkonova 2013</a>). This makes it appropriate to study late‐life depression separately from depression in younger adults. It also means that it would be useful to establish if there is a difference in treatment response between late‐onset and early‐onset illness. </p> </section> <section id="CD006727-sec-0039"> <h3 class="title" id="CD006727-sec-0039">Description of the intervention</h3> <p>A range of antidepressant medications are used to treat older people. They include older agents such as tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs), as well as newer agents such as selective serotonin reuptake inhibitors (SSRIs), serotonin‐noradrenaline reuptake inhibitors (SNRIs), noradrenergic and specific serotonergic antidepressants (NASSAs), and reversible inhibitors of monoamine oxidase A (RIMAs) (<a href="./references#CD006727-bbs2-0010" title="Abou‐SalehMT , KatonaC . Pharmacological treatment of depression. In: Abou‐SalehMT , KatonaC editor(s). Principles and Practice of Geriatric Psychiatry. 3rd Edition. Chichester: Wiley, 2010:537‐42. ">Abou‐Saleh 2010</a>). TCAs include imipramine and amitriptyline; SSRIs include sertraline and citalopram; SNRIs include venlafaxine; NASSAs include mirtazapine; and RIMAs include moclobemide. </p> <p>Several short‐term psychological therapies are used to treat older people with depression, including behavioural therapy, cognitive behavioural therapy (CBT), interpersonal therapy (IPT), and psychodynamic therapy. Behavioural therapy uses an operant conditioning model to reintroduce positive reinforcement, to reduce the time spent on negative events, and to overcome avoidance through behavioural activation. CBT begins with behavioural activation but also tackles the thought patterns that maintain inactivity and depressed mood by using direct verbal challenging and behavioural experiments. Problem‐solving therapy teaches a structured approach to tackling inactivity, lack of pleasurable activities, and dealing with psychosocial problems. Interpersonal psychotherapy focuses on the interplay between depression and interpersonal relationships. It uses patient education and a number of strategies such as role play and communication analysis to tackle obstacles in relationships (<a href="./references#CD006727-bbs2-0055" title="WilkinsonP . Psychotherapy of depression and dysthymia. Principles and Practice of Geriatric Psychiatry. 3rd Edition. Chichester: Wiley, 2010:543‐51. ">Wilkinson 2010</a>). Mindfulness‐based cognitive therapy combines teaching on the role of thought patterns in depression with training in meditation techniques (<a href="./references#CD006727-bbs2-0048" title="SegalZV , WilliamsJMG , TeasdaleJD . Mindfulness‐based Cognitive Therapy for Depression: a New Approach to Preventing Relapse. New York: Guilford Press, 2002. ">Segal 2002</a>). Psychodynamic psychotherapy focusses on the person's life review, losses experienced, attitudes to ageing, and the relationship with the therapist (<a href="./references#CD006727-bbs2-0025" title="GarnerJ . Psychological treatments: psychodynamic psychotherapy. Oxford Textbook of Old Age Psychiatry. Oxford: OUP, 2008:275‐83. ">Garner 2008</a>). Counselling, such as Rogerian person‐centred therapy, is an unstructured psychological therapy with an emphasis on warmth, genuineness, and empathy in the therapeutic relationship (<a href="./references#CD006727-bbs2-0057" title="ZaritSH , ZaritJM . Mental Disorders in Older Adults. New York: Guilford, 1998. ">Zarit 1998</a>). </p> <p>There is a small number of trials that support the efficacy of psychological therapies as acute phase interventions with older people, but fewer than with younger people (<a href="./references#CD006727-bbs2-0043" title="National Institute for Health and Care Excellence. The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90, 2010. www.nice.org.uk/Guidance/cg90 (accessed 8 August 2016). ">NICE 2010</a>). One Cochrane review found cognitive behavioural interventions to be superior to waiting list control in five trials, but the authors suggested caution in generalising this finding to clinical populations due to the small number of participants (<a href="./references#CD006727-bbs2-0056" title="WilsonK , MottramPG , VassilasC . Psychotherapeutic treatments for older depressed people. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD004853.pub2] ">Wilson 2008</a>). A more recent trial with 204 participants in primary care showed benefits of combining CBT with treatment as usual (including antidepressants) as compared with treatment as usual and treatment as usual plus a talking control (<a href="./references#CD006727-bbs2-0049" title="SerfatyM , HaworthD , BlanchardM , BuszewiczM , MuradS , KingM . Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care. Archives of General Psychiatry2009;66(12):1332‐40. ">Serfaty 2009</a>). </p> </section> <section id="CD006727-sec-0040"> <h3 class="title" id="CD006727-sec-0040">How the intervention might work</h3> <p>Older adults with depression are frequently prescribed antidepressants (<a href="./references#CD006727-bbs2-0045" title="PercudaniMBC , FortinoI , PetrovichL . Antidepressant drug prescribing among elderly subjects: a population‐based study. International Journal of Geriatric Psychiatry2005;20:113‐8. ">Percudani 2005</a>), and the short‐term response to treatment is generally good (<a href="./references#CD006727-bbs2-0032" title="KatonaCL , LivingstoneG . How well do antidepressants work in older people: a systematic review of number needed to treat. Journal of Affective Disorders2002;69:47‐52. ">Katona 2002</a>). Antidepressant action is thought to result from regulation of the monoamine neurotransmitter changes that occur in depressive illness. The rationale for continuing antidepressant treatment after clinical recovery, therefore, is that it will sustain regulation of monoamine activity. </p> <p>Individual CBT is as effective as antidepressants in reducing symptoms of depression and produces more enduring benefit than antidepressant treatment; it also appears to be better tolerated than antidepressants. Adding CBT to antidepressant treatment can also improve outcome in more severe depression and possibly in chronic depression (<a href="./references#CD006727-bbs2-0043" title="National Institute for Health and Care Excellence. The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90, 2010. www.nice.org.uk/Guidance/cg90 (accessed 8 August 2016). ">NICE 2010</a>). People with residual symptoms of depression after treatment have a poorer prognosis and psychological therapies may have an important role in reducing relapse and recurrence rates in these people (<a href="./references#CD006727-bbs2-0044" title="PaykelE , ScottJ , CornwallP , AbbottR , CraneC , PopeM , et al. Duration of relapse prevention after cognitive therapy in residual depression: follow‐up of controlled trial. Psychological Medicine2005;35:59‐68. ">Paykel 2005</a>). </p> <p>Interpersonal psychotherapy can be used as a short‐term acute phase treatment of depression (usually up to 16 sessions) or as a maintenance treatment with sessions more widely spaced over a period of months. The use of maintenance treatment allows for a greater number of therapeutic foci to be addressed including the long‐standing patterns of interpersonal behaviour that may contribute to recurrence (so‐called interpersonal deficits) (<a href="./references#CD006727-bbs2-0039" title="MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ">Miller 2003</a>). </p> <p>Maintenance CBT involves helping the person to continue to identify and address the behavioural and cognitive patterns associated with depressive relapse (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). CBT can continue to have a positive effect after it is discontinued (<a href="./references#CD006727-bbs2-0014" title="BlackburnIM , MooreRG . Controlled acute and follow‐up trial of cognitive therapy and pharmacotherapy in out‐patients with recurrent depression. British Journal of Psychiatry1997;171:328‐34. ">Blackburn 1997</a>), and, in younger adults, combining antidepressant medication and psychological therapies in the continuation phase produces better long‐term results than antidepressants alone (<a href="./references#CD006727-bbs2-0044" title="PaykelE , ScottJ , CornwallP , AbbottR , CraneC , PopeM , et al. Duration of relapse prevention after cognitive therapy in residual depression: follow‐up of controlled trial. Psychological Medicine2005;35:59‐68. ">Paykel 2005</a>). Mindfulness‐based cognitive therapy is an intervention partly derived from CBT that is used in the maintenance treatment of depression. It combines teaching in the cognitive model of depression with meditation‐based exercises (<a href="./references#CD006727-bbs2-0048" title="SegalZV , WilliamsJMG , TeasdaleJD . Mindfulness‐based Cognitive Therapy for Depression: a New Approach to Preventing Relapse. New York: Guilford Press, 2002. ">Segal 2002</a>) to help the individual to recognise when their mood is beginning to become low, and to develop the capacity to allow distressing mood, thoughts, and sensations to come and go without engaging with them. </p> <p>Psychodynamic therapy for depression is based on a model of vulnerability arising from early life experiences and disrupted childhood attachment. The relationship with the therapist is of key importance in identifying and fostering insight into psychological defence mechanisms. Psychodynamic therapy with the older person may help to develop a long‐term sense of contentment and acceptance of the losses and changes associated with ageing (<a href="./references#CD006727-bbs2-0025" title="GarnerJ . Psychological treatments: psychodynamic psychotherapy. Oxford Textbook of Old Age Psychiatry. Oxford: OUP, 2008:275‐83. ">Garner 2008</a>). </p> <p>As antidepressants and psychological therapies have different modes of action, combining them may produce greater benefits than either treatment alone. Psychological therapy may also include education on the benefits of antidepressant medication in order to foster treatment concordance. </p> </section> <section id="CD006727-sec-0041"> <h3 class="title" id="CD006727-sec-0041">Why it is important to do this review</h3> <p>This review adds to a programme of Cochrane reviews addressing the acute management of depression in older people with psychological therapies (<a href="./references#CD006727-bbs2-0056" title="WilsonK , MottramPG , VassilasC . Psychotherapeutic treatments for older depressed people. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD004853.pub2] ">Wilson 2008</a>) and antidepressants (<a href="./references#CD006727-bbs2-0042" title="MottramPG , WilsonK , StroblJJ . Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD003491.pub2] ">Mottram 2009</a>). </p> <p>The long‐term prognosis of late‐life depression is known to be poor, with around a quarter of people becoming depressed within two years of remission or recovery and a third experiencing one or more relapses after two years (<a href="./references#CD006727-bbs2-0017" title="ColeMG , BellevanceF . The prognosis of depression in old age. American Journal of Geriatric Psychiatry1997;5:4‐14. ">Cole 1997</a>). Therefore, it is important to identify treatments that will improve longer‐term outcome (i.e. reduce rates of recurrence and relapse). In younger adults, continuing antidepressant medication after remission reduces the odds of relapse by 70% with effects lasting up to 36 months, as long as medication is continued (<a href="./references#CD006727-bbs2-0026" title="GeddesJ , CarneyS , DaviesC , FurukawaT , KupferD , FrankE , et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet2003;361:653‐61. ">Geddes 2003</a>). </p> <p>Most previous reviews of trials with older adults have been narrative reviews and have focused on the acute treatment of depression (<a href="./references#CD006727-bbs2-0012" title="AreánPA , AlexopoulosGS . Psychosocial interventions for mental illness in late‐life. International Journal of Geriatric Psychiatry2007;22:99‐100. ">Areán 2007</a>). None have included both antidepressant medication and psychological therapies. This review includes trials of antidepressant medication, psychological therapies, and combinations of the two in the continuation and maintenance phase treatment of depression in adults aged 60 years and over. </p> <p>We anticipated that there would be few randomised controlled trials (RCTs) involving people aged 60 years and over. As many of these would be with small numbers of participants, a comprehensive review and meta‐analysis was required. It was also likely that there would be high withdrawal rates through physical illness, adverse effects, and death and it was possible that drop‐out rates would differ significantly between antidepressant treatment and psychological therapies. This review will help to identify the need for further studies. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006727-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006727-sec-0042"></div> <p>To examine the efficacy of antidepressants and psychological therapies in preventing the relapse and recurrence of depression in older people. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006727-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006727-sec-0043"></div> <section id="CD006727-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006727-sec-0045"> <h4 class="title">Types of studies</h4> <p>The review included all randomised controlled trials (RCTs), published and unpublished, including cluster‐randomised and cross‐over trials. </p> </section> <section id="CD006727-sec-0046"> <h4 class="title">Types of participants</h4> <p>Trial participants were aged 60 years or over, of either gender, who were in remission or who had recovered from a depressive episode diagnosed according to Diagnostic and Statistical Manual Criteria (DSM; <a href="./references#CD006727-bbs2-0011" title="American Psychiatric Association (APA). Diagnostic and Statistical Manual version IV. Washington, DC: American Psychiatric Association, 1994. ">APA 1994</a>), International Classification of Diseases (ICD; <a href="./references#CD006727-bbs2-0053" title="World Health Organization. International Classification of Diseases, 10th Revision. Geneva: World Health Organization, 1992. ">WHO 1992</a>), Research Diagnostic Criteria (RDC; <a href="./references#CD006727-bbs2-0020" title="FeighnerJP , RobinsE , GuzeSB , WoodruffRAJr , WinokurG , MunozR . Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry1972;26(1):57‐63. ">Feighner 1972</a>), Geriatric Mental State (GMS; <a href="./references#CD006727-bbs2-0018" title="CopelandJRM , KelleherMJ , KellettJM , GourlayAJ , GurlandBJ , FleissJL , et al. A semi‐structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. Development and reliability. Psychological Medicine1976;6(3):439‐49. ">Copeland 1976</a>), or as defined by trialists. The review included participants treated in a range of settings (inpatients, outpatients, community, care homes) and people with comorbid physical illness. The review also included studies in which some participants were aged under 60 years provided that data from those aged 60 years and over were separately analysed. The review included trial participants with both late‐onset depression (50 years or older) and early‐onset (under 50 years). Trials were included in which all participants had already responded to acute treatment (i.e. all were in continuation and maintenance phases) and trials in which only some participants had already responded. </p> <p>We excluded trials with participants experiencing bipolar disorder, dementia, and other severe mental disorders. </p> </section> <section id="CD006727-sec-0047"> <h4 class="title">Types of interventions</h4> <section id="CD006727-sec-0048"> <h5 class="title">Experimental interventions</h5> <p>Any antidepressant. There was no restriction on the dose of antidepressant treatment. All antidepressant drugs were eligible from the following classes. </p> <p> <ul id="CD006727-list-0001"> <li> <p>Tricyclic antidepressants (TCAs): amitriptyline, imipramine, trimipramine, doxepin, desipramine, protriptyline, nortriptyline, clomipramine, dothiepin, lofepramine. </p> </li> <li> <p>Selective serotonin reuptake inhibitors (SSRIs): zimelidine, fluvoxamine, fluoxetine, paroxetine, sertraline, citalopram, escitalopram. </p> </li> <li> <p>Serotonin‐noradrenaline antidepressants (SNRIs): venlafaxine, milnacipram, duloxetine.</p> </li> <li> <p>Noradrenergic and specific serotonergic antidepressants (NASSAs): mirtazapine.</p> </li> <li> <p>Monoamine oxidase inhibitors (MAOIs): <i>irreversible</i> : phenelzine, tranylcypromine, isocarboxazid; <i>reversible</i>: brofaramine, moclobemide, tyrima. </p> </li> <li> <p>Other antidepressants: noradrenaline reuptake inhibitors (NARIs): reboxetine, atomoxetine; noradrenaline‐dopamine reuptake inhibitors (NDRIs): amineptine, buproprion; serotonin antagonist and reuptake inhibitors (SARIs): trazodone; unclassified antidepressants: agomelatine, vilazodone; other heterocyclic antidepressants: mianserin, amoxapine, maprotiline. </p> </li> </ul> </p> <p>Any psychological therapy. Any structured psychological therapy of any duration was eligible, including the following. </p> <p> <ul id="CD006727-list-0002"> <li> <p>Behavioural therapy: activity scheduling, behaviour modification, psychoeducation.</p> </li> <li> <p>Cognitive behavioural therapy (CBT): problem‐solving therapy, rational emotive therapy, self control. </p> </li> <li> <p>Third‐wave CBTs: mindfulness, acceptance and commitment therapy, dialectical behaviour therapy. </p> </li> <li> <p>Integrative therapies: interpersonal therapy (IPT), cognitive analytical therapy.</p> </li> <li> <p>Psychodynamic therapies: brief psychological therapies, counter transference, psychoanalytic therapy. </p> </li> <li> <p>Humanistic therapies: existential therapy, experiential therapy.</p> </li> </ul> </p> <p>We categorised counselling according to the psychological therapy approach used by counselling practitioners. </p> </section> <section id="CD006727-sec-0049"> <h5 class="title">Comparator interventions</h5> <p> <ul id="CD006727-list-0003"> <li> <p>Placebo.</p> </li> <li> <p>Treatment as usual/waiting list control (provided these did not incorporate any of the excluded interventions). </p> </li> <li> <p>Antidepressants.</p> </li> <li> <p>Psychological therapies.</p> </li> </ul> </p> <p>We excluded electroconvulsive therapy (ECT), antipsychotic medication, or lithium used as continuation or maintenance treatments. </p> <p>We excluded psychological interventions, including systemic and family therapies, in which some recipients of therapy were not the index participant. </p> <p>We excluded studies in which there was no randomisation to treatment in the continuation and maintenance phase, that is, those in which acute phase treatment was simply continued after remission. </p> <p>For a list of main planned comparisons, see <a href="#CD006727-sec-0065">Data extraction and management</a>. </p> </section> </section> <section id="CD006727-sec-0050"> <h4 class="title">Types of outcome measures</h4> <section id="CD006727-sec-0051"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome measure for benefit was recurrence rate of depression at 12 months' follow‐up. We defined this as reaching a cut‐off on depression rating scales such as the Beck Depression Inventory (<a href="./references#CD006727-bbs2-0013" title="BeckAT , SteerRA , BrownGK . The Beck Depression Inventory. San Antonio, Texas: The Psychological Corporation, 1996. ">Beck 1996</a>), Hamilton Depression Rating Scale (HDRS; <a href="./references#CD006727-bbs2-0030" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry1960;23:56‐62. ">Hamilton 1960</a>), Montgomery‐Åsberg Depression Rating Scale (MADRS; <a href="./references#CD006727-bbs2-0040" title="MontgomeryS , ÅsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134:382‐9. ">Montgomery 1979</a>), or any depression symptom rating scale used by study authors. We defined remission of a depressive illness as depressive symptoms dropping below case level and defined recovery as remission lasting for more than six months. Recurrence was return to case level symptoms during recovery (<a href="./references#CD006727-bbs2-0022" title="FrankE , PrienR , JarrettRB , KellerMB , KupferDJ , LavoriPW , et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Archives of General Psychiatry1991;48:851‐5. ">Frank 1991</a>). </p> <p>The primary outcome measure for harm was number of participants who had dropped out during the trial at 12 months as a proportion of the total number of randomised participants. </p> </section> <section id="CD006727-sec-0052"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes for benefit were relapse and recurrence rates examined at six‐monthly intervals over the follow‐up period and at the point of final measurement (endpoint). We defined this as reaching a cut‐off on depression rating scales such as the Beck Depression Inventory (<a href="./references#CD006727-bbs2-0013" title="BeckAT , SteerRA , BrownGK . The Beck Depression Inventory. San Antonio, Texas: The Psychological Corporation, 1996. ">Beck 1996</a>), HDRS (<a href="./references#CD006727-bbs2-0030" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry1960;23:56‐62. ">Hamilton 1960</a>), MADRS (<a href="./references#CD006727-bbs2-0040" title="MontgomeryS , ÅsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134:382‐9. ">Montgomery 1979</a>), or any depression symptom rating scale used by study authors. We defined relapse as return to case level symptoms during remission and recurrence was return to case level symptoms during recovery (<a href="./references#CD006727-bbs2-0022" title="FrankE , PrienR , JarrettRB , KellerMB , KupferDJ , LavoriPW , et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Archives of General Psychiatry1991;48:851‐5. ">Frank 1991</a>). We defined remission of a depressive illness as depressive symptoms dropping below case level and defined recovery as remission lasting for more than six months. We included long‐term data after discontinuation of antidepressant medication if available. </p> <p>Where data were available, we also included the following secondary outcomes.</p> <p> <ul id="CD006727-list-0004"> <li> <p>Global clinical impression by the clinician (<a href="./references#CD006727-bbs2-0029" title="GuyW . Clinical Global Impressions: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 1976. ">Guy 1976</a>). </p> </li> <li> <p>Global clinical impression by the participant.</p> </li> <li> <p>Social functioning measured using the Global Assessment of Function scores (<a href="./references#CD006727-bbs2-0037" title="LuborskyL . Clinician's judgments of mental health. Archives of General Psychiatry1962;7:407‐17. ">Luborsky 1962</a>), or another scale used by the authors. </p> </li> <li> <p>Quality of life measured using the 36‐item Short Form (SF‐36) (<a href="./references#CD006727-bbs2-0052" title="WareJE , SnowKK , KosinskiM , GandekB . SF‐36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Centre, 1993. ">Ware 1993</a>). </p> </li> <li> <p>Deaths.</p> </li> </ul> </p> <section id="CD006727-sec-0053"> <h6 class="title">Acceptability</h6> <p>Acceptability was measured through number of participants who dropped out due to drug‐related adverse effects during the trial as a proportion of the total number of randomised participants (drop‐out rates due to drug‐related adverse effects). </p> </section> </section> </section> </section> <section id="CD006727-sec-0054"> <h3 class="title">Search methods for identification of studies</h3> <p>The Cochrane Common Mental Disorders Group maintains a specialised register of randomized controlled trials, the CCMDCTR. This register contains over 40,000 reference records (reports of RCTs) for anxiety disorders, depression, bipolar disorder, eating disorders, self‐harm and other mental disorders within the scope of this Group. The CCMDCTR is a partially studies based register with &gt;50% of reference records tagged to c12,500 individually PICO coded study records. Reports of trials for inclusion in the register are collated from (weekly) generic searches of Medline (1950‐), Embase (1974‐) and PsycINFO (1967‐), quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL) and review specific searches of additional databases. Reports of trials are also sourced from international trial registries, drug companies, the hand‐searching of key journals, conference proceedings and other (non‐Cochrane) systematic reviews and meta‐analyses. Details of <a href="http://cmd.cochrane.org/search-strategies-identification-studies" target="_blank">CCMD's core search strategies</a> (used to identify RCTs) can be found on the Group's website with an example of the core Medline search displayed in <a href="./appendices#CD006727-sec-0223">Appendix 2</a>. </p> <section id="CD006727-sec-0055"> <h4 class="title">Electronic searches</h4> <section id="CD006727-sec-0056"> <h5 class="title">1. Cochrane Common Mental Disorders Group's Specialised Register (CCMDCTR)</h5> <p>The Group's Information Specialist cross‐searched the CCMDCTR‐Refs and CCMDCTR‐Studies registers (to 13 July 2015) using the following updated search strategy (precision maximizing): </p> <p>#1 depress*:ti,ab,kw,ky,emt,mh<br/> #2 ((relapse or recurr* or maintenance or continuation or prophyla*) and (recovered or remission or remit* or responder* or "responded to" or "recent* episode" or "recent* depress*" or "previous* depress*" or "previous episode*" or (depress* near2 past))):ti,ab,kw,ky,emt,mh<br/> #3 ((continuation or maintenance) near2 (treatment* or *therap* or phase or antidepress* or medicat*)):ti,ab<br/> #4 “relapse prevention” or “time to relapse”<br/> #5 (aged or elder* or old or older or geriatric or "late* life" or institutional* or "care home*"):ti<br/> #6 Aged:kw,ky,sh,emt<br/> #7 (#1 and (#2 or #3 or #4) and (#5 or #6)) </p> <p>Key to search fields (Cochrane Register of Studies (CRS) platform):<br/> <i>ti:title; ab:abstract; kw:keywords;ky:additional keywords; emt:EMTREE headings; MH:MeSH</i> </p> <p>The Group's Information Specialist also conducted a cited reference search on the Web of Science (WoS) at this time (13‐Jul‐2015) for citations of primary reports of included studies. Results were screened for eligibility and any additional RCTs added to the CCMDCTR search results. </p> <p>Previous searches to June 2012 can be found in <a href="./appendices#CD006727-sec-0222">Appendix 1</a>. </p> </section> <section id="CD006727-sec-0057"> <h5 class="title">2. International trial registers</h5> <p>The World Health Organization's International Clinical Trials Registry Platform <a href="http://apps.who.int/trialsearch/" target="_blank">(ICTRP)</a> and <a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> were also searched at this time (13‐July‐2015). </p> </section> </section> <section id="CD006727-sec-0058"> <h4 class="title">Searching other resources</h4> <section id="CD006727-sec-0059"> <h5 class="title">Handsearches</h5> <p>We handsearched the following journals: <i>International Journal of Geriatric Psychiatry</i> ,<i>American Journal of Geriatric Psychiatry</i> ,<i>Journal of the American Geriatrics Association</i> , and <i>International Psychogeriatrics</i> . We screened relevant papers and major textbooks that covered late‐life depression and its treatment. <i>[Date]</i> </p> </section> <section id="CD006727-sec-0060"> <h5 class="title">Personal communication</h5> <p>We contacted the authors of significant papers and experts in the field for information on any unpublished studies. </p> </section> <section id="CD006727-sec-0061"> <h5 class="title">Bibliographies</h5> <p>We examined references and bibliographies from relevant trials for further RCTs not identified. </p> </section> <section id="CD006727-sec-0062"> <h5 class="title">Grey literature</h5> <p>We also searched grey literature, including conference abstracts of the International Psychogeriatrics Association<i>.[Date]</i> </p> </section> </section> </section> <section id="CD006727-sec-0063"> <h3 class="title" id="CD006727-sec-0063">Data collection and analysis</h3> <section id="CD006727-sec-0064"> <h4 class="title">Selection of studies</h4> <p>Both review authors independently performed the selection of trials for inclusion in the review by reviewing the titles and abstracts culled by the search strategy. Where a title or abstract appeared to describe a trial eligible for inclusion, we obtained the full‐text article to assess the relevance to this review based on the inclusion criteria. We attempted to resolve any disagreements by discussion. If agreement was not possible, we contacted the principle author of the study for further information to allow inclusion or exclusion. We generated a Cohen Kappa statistic to show level of agreement between the review authors. </p> </section> <section id="CD006727-sec-0065"> <h4 class="title">Data extraction and management</h4> <p>Both review authors independently extracted data using data extraction forms and evidence tables. We resolved differences by discussion. Both authors managed data entry into Review Manager (<a href="./references#CD006727-bbs2-0046" title="The Nordic Cochrane Centre. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We analysed included trials for the following characteristics. </p> <section id="CD006727-sec-0066"> <h5 class="title">Characteristics of the study participants</h5> <p> <ul id="CD006727-list-0005"> <li> <p>Age and any other recorded characteristics of participants.</p> </li> <li> <p>Location of participants.</p> </li> <li> <p>Methods used to define and diagnose study participants.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0067"> <h5 class="title">Interventions used</h5> <p> <ul id="CD006727-list-0006"> <li> <p>Type and stated aim of psychological therapy.</p> </li> <li> <p>Type of antidepressant medication.</p> </li> <li> <p>Type of placebo/control/comparison.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0068"> <h5 class="title">Measures</h5> <p> <ul id="CD006727-list-0007"> <li> <p>Assessment instruments.</p> </li> <li> <p>Assessment intervals.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0069"> <h5 class="title">Outcomes</h5> <section id="CD006727-sec-0070"> <h6 class="title">Primary</h6> <p> <ul id="CD006727-list-0008"> <li> <p>Relapse of depression.</p> </li> <li> <p>Recurrence of depressive disorder.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0071"> <h6 class="title">Secondary</h6> <p> <ul id="CD006727-list-0009"> <li> <p>Global clinical impression by clinician.</p> </li> <li> <p>Global clinical impression by the participant.</p> </li> <li> <p>Social functioning.</p> </li> <li> <p>Quality of life.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0072"> <h6 class="title">Acceptability:</h6> <p> <ul id="CD006727-list-0010"> <li> <p>Overall drop‐out rate.</p> </li> <li> <p>Drop‐out due to drug‐related adverse effects.</p> </li> <li> <p>Drop‐out due to death.</p> </li> </ul> </p> <p>When aspects of methodology were unclear, or when the data were in a form unsuitable for meta‐analysis and trials appeared to meet the eligibility criteria, we contacted the principal author for additional information. </p> </section> </section> <section id="CD006727-sec-0073"> <h5 class="title">Planned comparisons</h5> <p> <ul id="CD006727-list-0011"> <li> <p>Antidepressants versus placebo.</p> </li> <li> <p>Psychological therapies versus placebo or treatment as usual/waiting list.</p> </li> <li> <p>Antidepressants/psychological therapies combination versus drug placebo.</p> </li> <li> <p>Antidepressant versus psychological therapies.</p> </li> <li> <p>Antidepressant/psychological therapies combination versus antidepressants alone.</p> </li> <li> <p>Antidepressant/psychological therapies combination versus psychological therapies alone. </p> </li> </ul> </p> </section> </section> <section id="CD006727-sec-0074"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed trial quality using the Cochrane tool for assessing risk of bias. This tool assesses the following domains: sequence generation, allocation concealment, blinding, handling of incomplete data, selective reporting, and other sources of bias. Both review authors independently assessed each paper before agreeing on 'Risk of bias' assessments in each domain. We contacted investigators for additional information in cases of incomplete recording. </p> <p>We noted methods used for sequence generation and allocation concealment. We recorded methods for blinding participants, therapists, and assessors from treatment type along with evidence of effectiveness. In assessing incomplete outcome data, we assessed each main outcome at each time point for completeness including exclusions and attrition; we assessed methods for addressing incomplete data. To assess selective reporting, we compared stated outcomes with intended outcomes as stated in the methods sections and any available trial protocols. </p> <p>We made judgements for each domain as high risk of bias, low risk of bias, or unclear risk of bias. </p> </section> <section id="CD006727-sec-0075"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated risk ratios (RR) and their 95% confidence intervals (CI). When the overall results were significant, we calculated the number needed to treat for an additional beneficial outcome (NNTB) and additional harmful outcome (NNTH), as the inverse of the risk difference (RD). </p> <p>We presented mean differences (MD) for continuous data. Where necessary, we calculated standard deviations (SDs) from the study authors' CIs for MDs (<a href="./references#CD006727-bbs2-0031" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD006727-sec-0076"> <h4 class="title">Unit of analysis issues</h4> <p>In trials in which participants were treated individually, the unit of analysis was the participants. </p> <section id="CD006727-sec-0077"> <h5 class="title">Cluster‐randomised trials</h5> <p>In cluster‐randomised trials, participants in the same treatment group cannot be regarded as independent and an analysis that ignores clustering is likely to underestimate the standard error (SE) of the estimate. If study authors had taken account of clustering and reported data adjusted for possible within‐group correlation, we used the adjusted data in this review. If they did not report adjusted data, we contacted authors to obtain intra‐class correlation coefficients. </p> </section> <section id="CD006727-sec-0078"> <h5 class="title">Studies with multiple treatment groups</h5> <p>We analysed data from studies that compared more than two intervention groups using multiple pair‐wise comparisons between all possible pairs of intervention groups while taking care not to include the same group of participants more than once in the same meta‐analysis. </p> </section> <section id="CD006727-sec-0079"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trails evaluate the effect of experimental intervention compared with control intervention separately for each participant. Cross‐over design is unlikely in continuation and maintenance trials in depression, especially trials of psychological therapies that have carry‐over effects. As this review uses a point‐in‐time analysis comparing interventions at six monthly intervals from randomisation, data from cross‐over trials could not be included. </p> </section> </section> <section id="CD006727-sec-0080"> <h4 class="title">Dealing with missing data</h4> <p>We obtained missing data from authors, if available.</p> <p>We performed an intention‐to‐treat analysis in studies where more than 60% of people completed the study. We counted everyone allocated to the intervention, whether they completed the follow‐up or not. We assumed that those who dropped out had a negative outcome, with the exception of death. </p> </section> <section id="CD006727-sec-0081"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I<sup>2</sup> statistic as a test of heterogeneity with results interpreted according to the following broad thresholds: </p> <p> <ul id="CD006727-list-0012"> <li> <p>0% to 40%: may not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100%: represents considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0082"> <h4 class="title">Assessment of reporting biases</h4> <p>We entered data from included studies into a funnel graph in an attempt to identify the likelihood of significant publication bias. </p> </section> <section id="CD006727-sec-0083"> <h4 class="title">Data synthesis</h4> <p>We calculated the RR using the random‐effects model as this takes into account any differences between studies even if there is no statistically significant heterogeneity. We inspected data to see if an analysis using a fixed‐effect model would make any substantive difference in outcomes that were not statistically significantly heterogeneous. </p> <p>Where possible, we attempted to convert outcome measures to dichotomous data by identifying cut‐off points on rating scales and dividing participants accordingly into 'depression relapse/recurrence' or 'no relapse/recurrence of depression'. If the authors of a study had used a predefined cut‐off point for determining clinical effectiveness, we used this, where appropriate. Otherwise, we assumed that if there had been a 50% reduction in a scale‐derived score, this was interpreted as being a clinically significant response. </p> <p>We presented non‐quantitative data descriptively.</p> </section> <section id="CD006727-sec-0084"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored clinical heterogeneity, where possible, using the following subgroup analyses.</p> <p> <ul id="CD006727-list-0013"> <li> <p>Early‐onset depressive disorder and late‐onset depressive disorder in continuation and maintenance treatment. </p> </li> <li> <p>Response to treatment of participants (recovered) versus participants in remission.</p> </li> </ul> </p> </section> <section id="CD006727-sec-0085"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses to see if the results were affected by methodological decisions made throughout the review process. We undertook the following analyses to test the impact of including studies at high risk of bias. </p> <p> <ul id="CD006727-list-0014"> <li> <p>Removing studies at high risk of bias for allocation concealment.</p> </li> <li> <p>Removing studies at high risk of bias for blinding.</p> </li> <li> <p>Removing studies with a drop‐out rate above 20%.</p> </li> </ul> </p> <section id="CD006727-sec-0086"> <h5 class="title">'Summary of findings' table</h5> <p>We produced one 'Summary of findings' table for the two primary outcomes (recurrence and overall drop‐outs) at 12 months' follow‐up in the main comparison of interest, antidepressant versus placebo. There was no separation into high‐risk and low‐risk populations, as this was not possible using available data. We graded outcomes using the GRADE approach and produced the table using GRADEprofiler software (<a href="./references#CD006727-bbs2-0028" title="McMaster University. GRADEpro. McMaster University, 2014. ">GRADEpro</a>). We based the risk in the intervention group (and its 95% CI) on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006727-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006727-sec-0087"></div> <section id="CD006727-sec-0088"> <h3 class="title">Description of studies</h3> <section id="CD006727-sec-0089"> <h4 class="title">Results of the search</h4> <p>The updated search yielded 10 new records all of which we examined as full‐text articles and excluded as not meeting inclusion criteria. Therefore, the number of included studies remained unchanged from the previous review at seven studies (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). </p> <p>We produced an updated study flow diagram incorporating the studies included in the previous review (<a href="#CD006727-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD006727-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram (including studies in previous review version)." data-id="CD006727-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram (including studies in previous review version).</p> </div> </div> </div> </section> <section id="CD006727-sec-0090"> <h4 class="title">Included studies</h4> <p>The review included seven studies. See <a href="./references#CD006727-sec-0244" title="">Characteristics of included studies</a> table. </p> <section id="CD006727-sec-0091"> <h5 class="title">Types of studies</h5> <p>All seven included studies were of parallel design with participants allocated to therapeutic or control conditions. Four trials were multicentre (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>), and three were single centre (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). </p> <p>Five of the seven trials included two arms and compared antidepressant medication with drug placebo. Two used a TCA (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>), and three used an SSRI (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). One trial included two arms and compared continuation of any acute phase antidepressant with a combination of antidepressant and group CBT (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). One trial included four arms and compared a TCA, drug placebo, IPT/drug placebo combination, and TCA/IPT combination (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). </p> <p>Study size varied. One trial randomised 43 participants and another trial randomised 45 participants (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). One trial randomised 69 participants (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>), and three randomised between 107 and 121 participants (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). One trial randomised 305 participants (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>). </p> </section> <section id="CD006727-sec-0092"> <h5 class="title">Types of participants</h5> <section id="CD006727-sec-0093"> <h6 class="title">Diagnoses and measures of depression severity</h6> <p>Two trials required participants to have met DSM‐IV criteria for major depression (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). One trial used RDC (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>), one used both DSM‐IV and RDC (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>), one used Schedule for Affective Disorders and Schizophrenia ‐ Lifetime Version (SADS‐L) (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>), one used ICD‐10 criteria (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>), and one used both Automated Geriatric Examination for Computer Assisted Taxonomy (AGECAT) and DSM‐III (<a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). </p> <p>Five of the trials also required participants to have scored above a cut‐off on a depression rating scale. Three trials used the HDRS (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>) and two trials used the MADRS (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). </p> <p>Participants in all trials were in remission from depression before randomisation. All trials defined remission as scoring below a cut‐off on a depression rating scale. Four trials used the MADRS with cut‐offs of less than 13 (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>), less than 12 (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>), less than 11 (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>), and less than 10 (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). Two trials used the 17‐item HDRS with a cut‐off of less than 11 (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). One trial used the 24‐item HDRS with a cut‐off of less than 11 as well as the Cornell rating scale for depression with a cut‐off of less than 7 (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>). Two of the trials also required participants no longer to meet the diagnostic criteria for depression used for entry to the study (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). In all trials, participants were required to have been in a stable period of remission before randomisation. In the majority of trials, the period of remission was 16 weeks. In two trials, the required period of remission was shorter, that is, eight weeks (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>) and four weeks (<a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). One trial required a period of remission of between eight weeks and one year (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). </p> </section> <section id="CD006727-sec-0094"> <h6 class="title">Recruitment source</h6> <p>Four of the seven trials were based in psychiatry clinics in the USA and continental Europe (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). Authors described two of these clinics as research clinics (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). The other three trials were based in the UK National Health Service, recruiting people from primary and secondary care (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). Two of these included a proportion of participants who had received inpatient treatment (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>), and one included some participants who had been recruited through a research community survey (<a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). </p> </section> <section id="CD006727-sec-0095"> <h6 class="title">Participant characteristics</h6> <p>In keeping with the search strategy used, all participants were aged 60 years and over. Although the search had yielded many trials with adults of all ages that included a proportion of people aged 60 years and over, none of these analysed results separately from older participants and so we excluded all of them from the review. Three of the included trials recruited participants aged 65 years and over (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>); the remaining trials included participants aged 60 years and over. In six of the trials, the mean age was between 73 and 77 years; in the other trial, the mean was 67 years (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). In all trials, the majority of the participants were women. One trial stipulated that participants should have experienced at least one previous episode of major depression within the previous three years (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). One trial required participants to have experienced a depressive episode of at least four weeks' duration (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>). </p> </section> <section id="CD006727-sec-0096"> <h6 class="title">Exclusion criteria</h6> <p>All trials except one (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>) excluded people with severe or unstable physical illness. All except one (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>) used a single measure of cognitive function to exclude people with cognitive impairment. However, the degree of cognitive impairment for exclusion varied considerably between studies. Of six studies using the Folstein Mini Mental State Examination, the lowest cut‐off (representing the greatest degree of cognitive impairment) was 12 (<a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>), and the highest cut‐off (representing the smallest degree of cognitive impairment) was 27 (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). Two studies excluded people whose depressive episode had been treated with ECT (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>), and the two studies randomising to TCAs excluded people who were known to be unable to tolerate that class of antidepressant or who had contraindications to their use (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). </p> <p>Three trials excluded people who had been treated for psychotic depression (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). Three trials excluded people who had a history of any other psychiatric disorders, including bipolar disorder (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). One trial limited exclusion to bipolar disorder and dysthymia (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>), and one to bipolar disorder alone (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). </p> </section> </section> <section id="CD006727-sec-0097"> <h5 class="title">Types of intervention </h5> <section id="CD006727-sec-0098"> <h6 class="title">Antidepressant drugs and drug placebo interventions</h6> <p>All trials except one (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>) involved comparison of active antidepressant treatment with antidepressant placebo. Three of these trials used TCAs. One trial adjusted nortriptyline dose to achieve a plasma level of 60 ng/mL to 150 ng/mL, while people randomised to placebo underwent titration from nortriptyline over a 10‐week period; all participants continued to attend a medication clinic (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>). The second trial adjusted nortriptyline dose to achieve a plasma level of 80 ng/mL to 120 ng/mL with people randomised to placebo undergoing a six‐week titration; all participants continued to attend a medication clinic (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). In the third trial using TCAs, all participants in the active treatment arm received dothiepin 75 mg daily (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>). None of the study authors specified titration arrangements for participants randomised to placebo. </p> <p>The other three trials comparing active treatment with placebo antidepressant used SSRIs. <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a> used escitalopram at 10 mg or 20 mg daily, according to the dose required during active treatment. Participants randomised to receive placebo underwent direct switch from escitalopram 10 mg daily or titration over one week from 20 mg daily. <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a> used citalopram at 20 mg, 30 mg, or 40 mg daily, according to the dose required during acute treatment; they did not specify titration procedures for participants randomised to placebo. <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a> used sertraline at a dose of 50 mg, 100 mg, or 150 mg daily according to the dose used in the acute phase treatment except with participants who had required a dose of 200 mg in the acute phase who had this reduced to 150 mg. They did not specify titration procedures for participants randomised to placebo. </p> <p><a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a> compared nortriptyline at a plasma level of 80 ng/mL to 120 ng/mL and medication clinic attendance with nortriptyline titrated for four weeks after randomisation to achieve a lower plasma level of 40 ng/mL to 60 ng/mL with medication clinic attendance. In <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>, all participants in both arms continued to receive whichever antidepressant had been used in their acute phase treatment. </p> </section> <section id="CD006727-sec-0099"> <h6 class="title">Types of psychological therapies</h6> <p>Only two trials included psychological therapies. One trial used IPT (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). Treatment sessions were delivered on a monthly basis throughout the whole period of follow‐up, that is, for three years or until recurrence or drop‐out. Reference is made to use of a therapy manual. The other trial to involve a psychological therapies used eight sessions of group CBT over a fixed 12‐week period (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). This was a standardised therapy using a treatment manual and therapy homework, including usual cognitive behavioural techniques of activity scheduling, thought monitoring, and thought challenging. </p> </section> <section id="CD006727-sec-0100"> <h6 class="title">Process evaluation of psychotherapeutic evaluation</h6> <p><a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a> audiotaped IPT sessions and rated them for treatment integrity and compliance with the treatment manual. Although not explicitly stated, a reference indicated that a rating tool was used (<a href="./references#CD006727-bbs2-0051" title="WagnerEF , FrankE , SteinerSC . Discriminating maintenance treatments for recurrent depression: development and implementation of a rating scale. Journal of Psychotherapy Practice and Research1992;22:281‐91. ">Wagner 1992</a>), although compliance ratings are not given. <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a> videotaped group CBT sessions and rated a 25% sample for therapy quality and adherence to the treatment manual using a modified version of the Cognitive Therapy Rating Scale (<a href="./references#CD006727-bbs2-0015" title="BlackburnI , JamesIA , Milne DL , BakerC , Standart S , Garland A , et al. The Revised Cognitive Therapy Scale (CTS‐R): psychometric properties. Behavioural and Cognitive Psychotherapy2001;29:431‐46. ">Blackburn 2001</a>). All sessions achieved the predetermined level of therapy competence, apart from the sessions from the first group treated. </p> </section> </section> <section id="CD006727-sec-0101"> <h5 class="title">Types of outcome measures</h5> <section id="CD006727-sec-0102"> <h6 class="title">Primary outcomes</h6> <p>Primary outcome measures were rates of recurrence of depression using predetermined cut‐offs on different depression rating scales, diagnostic criteria, or clinical judgement. One study used the 17‐item HDRS requiring a score of 13 or more (<a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). Another study used the 24‐item HDRS, requiring a score of 17 or more (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>). Four studies used the MADRS, two requiring a score of 22 or more (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>), one a score of 11 or more (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>), and the other a score of 10 or more (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). Three studies also allowed recurrence to be identified by clinical judgement (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>), one by RDC (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>), and one by DSM‐IIIR criteria (<a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). </p> </section> <section id="CD006727-sec-0103"> <h6 class="title">Secondary outcomes</h6> <p>No study reported long‐term recurrence rates of depression after discontinuation of treatments. One study measured changes in observer‐rated Clinical Global Impression (CGI) (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>). No studies reported social functioning measures or quality of life measures. Six of the seven studies reported death rates; one study did not state death rates (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>), but it was apparent that no deaths occurred during follow‐up. One study reported overall drop‐out rates without identifying drop‐outs specifically due to adverse effects and deaths, and the study authors provided no further data (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>). </p> </section> <section id="CD006727-sec-0104"> <h6 class="title">Acceptability</h6> <p>Six of the seven studies reported overall drop‐out rates. One study did not state drop‐out rates, but it was apparent that no drop‐outs occurred during follow‐up (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>). Three of the studies reported drop‐out rates due to drug‐related adverse effects (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). One study reported overall drop‐out rates without identifying drop‐outs specifically due to adverse effects and deaths, and study authors provided no further data (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>). </p> </section> </section> </section> <section id="CD006727-sec-0105"> <h4 class="title">Excluded studies</h4> <p>The most frequent reason for exclusion of studies was inclusion in trials of participants aged 60 years and over with younger adults, with no separate analysis of data from older participants. We excluded two trials by Reynolds et al., one because it compared two serum levels of the same antidepressant (<a href="./references#CD006727-bbs2-0008" title="ReynoldsCFIII , PerelJM , FrankE , CornesC , MillerMD , HouckPR , et al. Three‐year outcomes of maintenance nortriptyline treatment in late‐life depression: a study of two fixed plasma levels. American Journal of Psychiatry1999;156(8):1177‐81. ">Reynolds 1999b</a>), and the other because some participants received augmentation with lithium or perphenazine, which was not discontinued at randomisation (<a href="./references#CD006727-bbs2-0009" title="CarreiraK , MillerMD , FrankE , HouckPR , MorseJQ , DewMA , et al. A controlled evaluation of monthly maintenance Interpersonal psychotherapy in late‐life depression with varying levels of cognitive function. International Journal of Geriatric Psychiatry2008;23:1110‐3. DombrovskiAY , LenzeEJ , DewMA , MulsantBH , PollockBG , HouckPR , et al. Maintenance treatment for old‐age depression preserves health‐related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Journal of the American Geriatrics Society2007;55(9):1325‐32. ReynoldsCF , DewMA , PollockBG , MulsantBH , FrankE , MillerMD , et al. Maintenance treatment of major depression in old age. New England Journal of Medicine2006;354:1130‐8. ">Reynolds 2006</a>). See <a href="./references#CD006727-sec-0245" title="">Characteristics of excluded studies</a> table. </p> <section id="CD006727-sec-0106"> <h5 class="title">Studies awaiting classification</h5> <p>We identified no studies awaiting classification.</p> </section> <section id="CD006727-sec-0107"> <h5 class="title">Ongoing studies</h5> <p>We identified no ongoing studies.</p> </section> </section> </section> <section id="CD006727-sec-0108"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD006727-fig-0002">Figure 2</a> and <a href="#CD006727-fig-0003">Figure 3</a> for summary graphs. </p> <div class="figure" id="CD006727-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006727-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006727-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006727-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006727-sec-0109"> <h4 class="title">Allocation</h4> <section id="CD006727-sec-0110"> <h5 class="title">Sequence generation</h5> <p>All studies used adequate sequence generation. All reported using random allocation, although not all studies stated the randomisation method. Two studies also employed stratification (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). </p> </section> <section id="CD006727-sec-0111"> <h5 class="title">Allocation concealment</h5> <p>Four studies used adequate allocation concealment (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). Allocation concealment was unclear in the remaining studies. </p> </section> </section> <section id="CD006727-sec-0112"> <h4 class="title">Blinding</h4> <section id="CD006727-sec-0113"> <h5 class="title">Blinding of participants</h5> <p>The six studies that investigated antidepressant medication achieved blinding of participants using placebo arms (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). The two trials involving psychological therapies could not achieve blinding of participants as psychological therapies involve active participation from people receiving the treatment (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). </p> </section> <section id="CD006727-sec-0114"> <h5 class="title">Blinding of those delivering treatment</h5> <p>There was adequate blinding of those delivering treatment in four of the studies (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). Blinding was unclear in two of the studies (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). In the two studies with psychological therapy arms, blinding was not possible (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). </p> </section> <section id="CD006727-sec-0115"> <h5 class="title">Blinding of assessors</h5> <p>Blinding of assessors was adequate in five of the studies (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>), and unclear in one (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>). Blinding inadequate in <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a> as the study authors report that, during follow‐up assessments, some participants used terms that indicated they had become familiar with CBT, the intervention under investigation, causing unblinding of the assessor. </p> </section> </section> <section id="CD006727-sec-0116"> <h4 class="title">Incomplete outcome data</h4> <p>All studies addressed incomplete data (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). </p> </section> <section id="CD006727-sec-0117"> <h4 class="title">Selective reporting</h4> <p>Only one study was free from selective reporting as the study protocol was available to the authors (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). There were no other study protocols available so risk of bias in the other six studies was uncertain. </p> </section> <section id="CD006727-sec-0118"> <h4 class="title">Other potential sources of bias</h4> <p>All seven studies involved antidepressant medication; one involved a range of medications (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>), while the others involved single agents. Involvement by pharmaceutical companies in trials may introduce bias as companies hold a vested interest in the results. Three studies were funded by pharmaceutical companies (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). The funding of <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a> was unclear but employees of a pharmaceutical company were among the investigators. The funding of <a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a> was also unclear. Independent grant‐giving bodies funded the remaining studies (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). </p> <p>Six of the seven studies involved titration from active antidepressant to placebo antidepressant (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). This can introduce bias through carry‐over therapeutic effects if titration is slow, or by discontinuation symptoms if titration is rapid. Two studies described gradual tapering of antidepressant dose under double‐blind conditions; in one study, this was over 10 weeks (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>), and in the other study was over six weeks (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). In <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>, participants randomised to receive placebo underwent direct switch from escitalopram 10 mg daily or titration over one week from escitalopram 20 mg daily. The remaining studies did not state the procedures for titration (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). </p> <p>Two trials included delivery of psychological treatments (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). Poor treatment fidelity is a potential source of bias in psychological treatment trials. However, both trials used psychological therapists with high levels of training and included supervision in the relevant therapy (IPT (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) and group CBT (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>)). Both trials also used a therapist competency scale to measure treatment fidelity. Therefore, this potential source of bias was low in these studies. </p> <p>Studies reported different drop‐out rates. Higher rates of drop‐out may occur in people taking active medication and experiencing adverse effects, leading to bias. </p> </section> </section> <section id="CD006727-sec-0119"> <h3 class="title" id="CD006727-sec-0119">Effects of interventions</h3> <p>See: <a href="./full#CD006727-tbl-0001"><b>Summary of findings for the main comparison</b> Antidepressant medication compared with placebo at 12 months' follow‐up</a> </p> <p>We performed intention‐to‐treat analyses in all comparisons.</p> <section id="CD006727-sec-0120"> <h4 class="title">1. Antidepressants versus placebo</h4> <section id="CD006727-sec-0121"> <h5 class="title">Primary outcomes</h5> <section id="CD006727-sec-0122"> <h6 class="title">1.1 Recurrence rate of depression at 12 months</h6> <p>There was a statistically significant difference favouring antidepressants in reducing recurrence at 12 months compared with placebo (three RCTs, n = 247, RR 0.67, 95% CI 0.55 to 0.82) (<a href="#CD006727-fig-0004">Figure 4</a>). This translated to an NNTB of 5. Fixed‐effect modelling found the same effect. We downgraded the outcome from high to low quality of evidence due to imprecision and risk of bias. </p> <div class="figure" id="CD006727-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence." data-id="CD006727-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence.</p> </div> </div> </div> <p><b>1.2 Overall drop‐out rates at 12 months</b> </p> <p>There was no difference in drop‐out rates at 12 months (one RCT, n = 121). We downgraded the outcome from high to low quality of evidence due to imprecision. </p> </section> </section> <section id="CD006727-sec-0123"> <h5 class="title">Secondary outcomes</h5> <section id="CD006727-sec-0124"> <h6 class="title">1.3 Relapse/recurrence rates of depression at other time points</h6> <p>There was no significant reduction in relapse rates at six months in people taking antidepressants compared with people taking placebo (three RCTs, n = 487; <a href="#CD006727-fig-0004">Figure 4</a>). There was a high degree of heterogeneity between the three trials in this analysis (I<sup>2</sup> = 78%), the possible reason being that two of the trials used a lower cut‐off to determine relapse, and they included people from secondary care (who had probably been more severely depressed) (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0007" title="Abou‐SalehM , Abou‐SalehMT , WilsonK . Prevention of relapse recurrence of depression: sertraline vs placebo in the elderly. XII World Congress of Psychiatry; 2002 Aug 24‐29; Yokohama, Japan. 2002. WilsonKCM , MottramPG , AshworthL , Abou‐SalehMT . Older community residents with depression: long‐term treatment with sertraline. British Journal of Psychiatry2003;182:492‐7. ">Wilson 2003</a>). Excluding these two trials from the analysis resulted in a significant benefit of antidepressant treatment in the one remaining trial (<a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>). </p> <p>There was no significant reduction in recurrence rates at 18 months in people taking antidepressants compared with people taking placebo in the one trial yielding data (one RCT, n = 69; <a href="#CD006727-fig-0004">Figure 4</a>). </p> <p>There was no significant reduction in recurrence rates at 24 months in people taking antidepressants compared with people taking placebo (four RCTs, n = 282; <a href="#CD006727-fig-0004">Figure 4</a>). There was a moderate degree of heterogeneity between the four trials in this analysis (I<sup>2</sup> = 37%), with one trial being an outlier (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>). When we removed this trial from the analysis, the heterogeneity was reduced (I<sup>2</sup> = 0%) but the result remained insignificant. </p> <p>In the three trials of TCAs, antidepressant treatment was superior to placebo at 24 months. </p> <p>There was a significant difference favouring the antidepressant group in reducing recurrence at 36 months compared with placebo in the one trial reporting data at 36 months (n = 57, RR 0.64, 95% CI 0.45 to 0.90; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0004">Figure 4</a>). This translated to an NNTB of 4. Participants in this trial were generally younger, less cognitively impaired, and experienced less physical illness than participants in other trials in the review. </p> </section> <section id="CD006727-sec-0125"> <h6 class="title">1.4 Global clinical impression by the clinician</h6> <p>One study presented continuous data measuring changes in observer‐rated CGI (n = 305; <a href="./references#CD006727-bbs2-0002" title="DolbergO , LonnLS , KvistK . Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting. Current Medical Research and Opinion2014;30(7):1301‐7. [10.1185/03007995.2014.904770] GorwoodP , WeillerE , LemmingO , KatonaC . Escitalopram prevents relapse in older patients with major depressive disorder. American Journal of Geriatric Psychiatry2007;15(7):581‐93. LyketsosCG , WeillerE , KatonaC , GorwoodP . Are old‐old patients with major depression more likely to relapse than young‐old patients during continuation treatment with escitalopram?. BMC Geriatrics2011;11:2. ">Gorwood 2007</a>) as MDs using SDs calculated from the study authors' CIs for MDs (<a href="./references#CD006727-bbs2-0031" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). There was no significant difference in symptom severity between antidepressant and placebo at six months. </p> </section> <section id="CD006727-sec-0126"> <h6 class="title">1.5 Global clinical impression by the participant</h6> <p>We found no data on global clinical impression by the participant.</p> </section> <section id="CD006727-sec-0127"> <h6 class="title">1.6 Social functioning</h6> <p>We found no data on social functioning.</p> </section> <section id="CD006727-sec-0128"> <h6 class="title">1.7 Quality of life</h6> <p>We found no data on quality of life.</p> </section> <section id="CD006727-sec-0129"> <h6 class="title">1.8 Deaths</h6> <p>Comparison of death rates was possible for antidepressant versus placebo at 24 and 36 months, and antidepressant versus combination of antidepressant and psychological therapies at six and 12 months. There were no significant differences in any of these analyses. </p> </section> <section id="CD006727-sec-0130"> <h6 class="title">1.9 Acceptability: overall drop‐out rates at other time points</h6> <p>Comparison of overall drop‐out rates (excluding deaths) was possible for antidepressant medication versus placebo at six months (one RCT, n = 305), 24 months (one RCT, n = 113), and 36 months (one RCT, n = 57). There were no significant differences (<a href="#CD006727-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD006727-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.6 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.6 Overall drop‐out rates (excluding deaths). </p> </div> </div> </div> </section> <section id="CD006727-sec-0131"> <h6 class="title">1.10 Acceptability: drop‐out rates due to drug‐related adverse effects</h6> <p>There were no significant differences in drop‐outs due to drug‐related adverse effects in the analyses at six months (one RCT, n = 305), 12 months (one RCT, n = 121), or 24 months (one RCT, n = 234). Only one trial reported qualitative data on adverse effects encountered at a statistically greater frequency with antidepressant (citalopram) than with placebo (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). These were increased sweating, tremor, and fatigue. </p> </section> </section> </section> <section id="CD006727-sec-0132"> <h4 class="title">2. Psychological therapies versus placebo or treatment as usual/waiting list</h4> <section id="CD006727-sec-0133"> <h5 class="title">Primary outcomes</h5> <section id="CD006727-sec-0134"> <h6 class="title">2.1 Recurrence rate of depression at 12 months</h6> <p>In the one trial comparing psychological therapies (IPT) with placebo medication (n = 54; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>), there was no significant difference in recurrence at 12 months. </p> </section> <section id="CD006727-sec-0135"> <h6 class="title">2.2 Overall drop‐out rate at 12 months</h6> <p>We found no data on overall drop‐out rate at 12 months.</p> </section> </section> <section id="CD006727-sec-0136"> <h5 class="title">Secondary outcomes</h5> <section id="CD006727-sec-0137"> <h6 class="title">2.3 Relapse/recurrence rate of depression at other time points</h6> <p>In the one trial comparing psychological therapies (IPT) with placebo medication (n = 54; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>), there was no significant difference in recurrence at 24 months. </p> <p>In the one trial comparing psychological therapies (IPT) with placebo medication (n = 54; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>), there was no significant difference in recurrence at 36 months. </p> </section> <section id="CD006727-sec-0138"> <h6 class="title">2.4 Global clinical impression by the clinician</h6> <p>We found no data on global clinical impression by the clinician.</p> </section> <section id="CD006727-sec-0139"> <h6 class="title">2.5 Global clinical impression by the participant</h6> <p>We found no data on global clinical impression by the participant.</p> </section> <section id="CD006727-sec-0140"> <h6 class="title">2.6 Social functioning</h6> <p>We found no data on social functioning.</p> </section> <section id="CD006727-sec-0141"> <h6 class="title">2.7 Quality of life</h6> <p>We found no data on quality of life.</p> </section> <section id="CD006727-sec-0142"> <h6 class="title">2.8 Deaths</h6> <p>We found no data on deaths.</p> </section> <section id="CD006727-sec-0143"> <h6 class="title">2.9 Acceptability: overall drop‐out rate</h6> <p>One study yielded data to compare overall drop‐out rates (excluding deaths) at 36 months in the comparisons of antidepressant versus psychological therapies, psychological therapies versus placebo, and combination of antidepressant and placebo versus psychological therapies alone (n = 54; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). There were no significant differences in any of these three comparisons. </p> </section> <section id="CD006727-sec-0144"> <h6 class="title">2.10 Acceptability: drop‐out rates due to drug‐related adverse effects</h6> <p>We found no data on drop‐out rates due to drug‐related adverse effects.</p> </section> </section> </section> <section id="CD006727-sec-0145"> <h4 class="title">3. Antidepressants/psychological therapies combination versus drug placebo</h4> <section id="CD006727-sec-0146"> <h5 class="title">Primary outcomes</h5> <section id="CD006727-sec-0147"> <h6 class="title">3.1 Recurrence rate of depression at 12 months</h6> <p>There was a significant difference at 12 months favouring combination in the one trial comparing antidepressant/psychological therapies combination with drug placebo alone (n = 54, RR 0.42, 95% CI 0.23 to 0.77; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD006727-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 7 Antidepressant/psychological therapies combination versus drug placebo, outcome: 7.1 Recurrence." data-id="CD006727-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 7 Antidepressant/psychological therapies combination versus drug placebo, outcome: 7.1 Recurrence. </p> </div> </div> </div> </section> <section id="CD006727-sec-0148"> <h6 class="title">3.2 Overall drop‐out rate at 12 months</h6> <p>There was no significant difference in overall drop‐out rate at 12 months (one RCT; n =54). </p> </section> </section> <section id="CD006727-sec-0149"> <h5 class="title">Secondary outcomes</h5> <section id="CD006727-sec-0150"> <h6 class="title">3.3 Relapse/recurrence rate of depression at other time points</h6> <p>There was a significant difference at 24 months favouring combination in the one trial comparing antidepressant/psychological therapies combination with drug placebo alone n = 54, RR 0.39, 95% CI 0.21 to 0.70; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0006">Figure 6</a>). </p> <p>There was a significant difference at 36 months favouring combination in the one trial comparing antidepressant/psychological therapies combination with drug placebo alone (n = 54, RR 0.36, 95% CI 0.20 to 0.64; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0006">Figure 6</a>). </p> </section> <section id="CD006727-sec-0151"> <h6 class="title">3.4 Global clinical impression by the clinician</h6> <p>We found no data on global clinical impression by the clinician.</p> </section> <section id="CD006727-sec-0152"> <h6 class="title">3.5 Global clinical impression by the participant</h6> <p>We found no data on global clinical impression by the participant.</p> </section> <section id="CD006727-sec-0153"> <h6 class="title">3.6 Social functioning</h6> <p>We found no data on social functioning.</p> </section> <section id="CD006727-sec-0154"> <h6 class="title">3.7 Quality of life</h6> <p>We found no data on quality of life.</p> </section> <section id="CD006727-sec-0155"> <h6 class="title">3.8 Deaths</h6> <p>We found no data on deaths.</p> </section> <section id="CD006727-sec-0156"> <h6 class="title">3.9 Acceptability: overall drop‐out rate at other time points</h6> <p>Comparison of overall drop‐out rates (excluding deaths) was possible for combination of antidepressant and psychological therapies with placebo at six, 12, and 24 months, with no significant differences found (one RCT; n =54). </p> </section> <section id="CD006727-sec-0157"> <h6 class="title">3.10 Acceptability: drop‐out rates due to drug‐related adverse effects</h6> <p>We found no data on drop‐out rates due to drug‐related adverse effects.</p> </section> </section> </section> <section id="CD006727-sec-0158"> <h4 class="title">4. Antidepressant versus psychological therapies</h4> <section id="CD006727-sec-0159"> <h5 class="title">Primary outcomes</h5> <section id="CD006727-sec-0160"> <h6 class="title">4.1 Recurrence rate of depression at 12 months</h6> <p>There was no significant difference in recurrence rates at 12 months in people taking an antidepressant compared with people receiving psychological therapies in the one trial comparing recurrence rate of depression at 12 months (n = 53, RR 0.82, 95% CI 0.47 to 1.46; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD006727-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Antidepressant versus psychological therapies, outcome: 2.1 Recurrence." data-id="CD006727-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antidepressant versus psychological therapies, outcome: 2.1 Recurrence. </p> </div> </div> </div> </section> <section id="CD006727-sec-0161"> <h6 class="title">4.2 Overall drop‐out rate at 12 months</h6> <p>We found no data on overall drop‐out rate at 12 months.</p> </section> </section> <section id="CD006727-sec-0162"> <h5 class="title">Secondary outcomes</h5> <section id="CD006727-sec-0163"> <h6 class="title">4.3 Relapse/recurrence rate of depression at other time points</h6> <p>There was no significant difference in recurrence rate at 24 months in people taking an antidepressant compared with people receiving psychological therapies in the one trial comparing relapse/recurrence rate of depression at other time points (n = 53, RR 0.71, 95% CI 0.49 to 1.04; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0007">Figure 7</a>). </p> </section> <section id="CD006727-sec-0164"> <h6 class="title">4.4 Global clinical impression by the clinician</h6> <p>We found no data on global clinical impression by the clinician.</p> </section> <section id="CD006727-sec-0165"> <h6 class="title">4.5 Global clinical impression by the participant</h6> <p>We found no data on global clinical impression by the participant.</p> </section> <section id="CD006727-sec-0166"> <h6 class="title">4.6 Social functioning</h6> <p>We found no data on social functioning.</p> </section> <section id="CD006727-sec-0167"> <h6 class="title">4.7 Quality of life</h6> <p>We found no data on quality of life.</p> </section> <section id="CD006727-sec-0168"> <h6 class="title">4.8 Deaths</h6> <p>We found no data on deaths.</p> </section> <section id="CD006727-sec-0169"> <h6 class="title">4.9 Acceptability: overall drop‐out rate</h6> <p>One study yielded data to compare overall drop‐out rates (excluding deaths) at 36 months in the comparisons of antidepressant versus psychological therapies, psychological therapies versus placebo, and combination of antidepressant and placebo versus psychological therapies alone (n = 54; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). There were no significant differences in any of these three comparisons. </p> </section> <section id="CD006727-sec-0170"> <h6 class="title">4.10 Acceptability: drop‐out rates due to drug‐related adverse effects</h6> <p>We found no data on drop‐out rates due to drug‐related adverse effects.</p> </section> </section> </section> <section id="CD006727-sec-0171"> <h4 class="title">5. Antidepressant/psychological therapies combination versus antidepressants alone</h4> <section id="CD006727-sec-0172"> <h5 class="title">Primary outcomes</h5> <section id="CD006727-sec-0173"> <h6 class="title">5.1 Recurrence rate of depression at 12 months</h6> <p>There was no significant difference in recurrence at 12 months in people receiving antidepressant/psychological therapies combination compared with people receiving antidepressant alone. There were two trials in this analysis (n = 98) with low heterogeneity (<a href="#CD006727-fig-0008">Figure 8</a>). This analysis also included data from <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>, which the study authors adjusted for clustering. </p> <div class="figure" id="CD006727-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Antidepressant/psychological therapies combination versus antidepressant alone, outcome: 5.1 Recurrence." data-id="CD006727-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Antidepressant/psychological therapies combination versus antidepressant alone, outcome: 5.1 Recurrence. </p> </div> </div> </div> </section> <section id="CD006727-sec-0174"> <h6 class="title">5.2 Overall drop‐out rates at 12 months</h6> <p>We found no data on overall drop‐out rates at 12 months.</p> </section> </section> <section id="CD006727-sec-0175"> <h5 class="title">Secondary outcomes</h5> <section id="CD006727-sec-0176"> <h6 class="title">5.3 Relapse/recurrence rate of depression at other time points</h6> <p>In the one trial reporting relevant data, there was no significant reduction in relapse at six months in people receiving antidepressant/psychological therapies combination compared with people receiving antidepressant alone (n = 45; <a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>) (<a href="#CD006727-fig-0008">Figure 8</a>). This was a group‐based intervention; the study authors adjusted the calculation of RR to allow for clustering. </p> <p>In the one trial reporting data, there was no significant reduction in recurrence at 24 months in people receiving antidepressant/psychological therapies combination compared with people receiving antidepressant alone (n = 53; <a href="#CD006727-fig-0008">Figure 8</a>). </p> <p>In the one trial reporting data, there was no significant reduction in recurrence at 36 months in people receiving antidepressant/psychological therapies combination compared with people receiving antidepressant alone (n = 53; <a href="#CD006727-fig-0008">Figure 8</a>). </p> </section> <section id="CD006727-sec-0177"> <h6 class="title">5.4 Global clinical impression by the clinician</h6> <p>We found no data on global clinical impression by the clinician.</p> </section> <section id="CD006727-sec-0178"> <h6 class="title">5.5 Global clinical impression by the participant</h6> <p>We found no data on Global clinical impression by the participant.</p> </section> <section id="CD006727-sec-0179"> <h6 class="title">5.6 Social functioning</h6> <p>We found no data on social functioning.</p> </section> <section id="CD006727-sec-0180"> <h6 class="title">5.7 Quality of life</h6> <p>We found no data on quality of life.</p> </section> <section id="CD006727-sec-0181"> <h6 class="title">5.8 Deaths</h6> <p>Comparison of death rates was possible for combination of antidepressant and psychological therapy versus antidepressant alone at six months (one RCT, n = 45), 12 months (two RCTs, n = 98), 24 months (one RCT, n = 53), and 36 months (one RCT; n = 53). There were no significant differences in any of these analyses. </p> </section> <section id="CD006727-sec-0182"> <h6 class="title">5.9 Acceptability: overall drop‐out rate</h6> <p>We found no data on overall drop‐out rate.</p> </section> <section id="CD006727-sec-0183"> <h6 class="title">5.10 Acceptability: drop‐out rates due to drug‐related adverse effects</h6> <p>We found no data on drop‐out rates due to drug‐related adverse effects.</p> </section> </section> </section> <section id="CD006727-sec-0184"> <h4 class="title">6. Antidepressants/psychological therapies combination versus psychological therapies alone </h4> <section id="CD006727-sec-0185"> <h5 class="title">Primary outcomes</h5> <section id="CD006727-sec-0186"> <h6 class="title">6.1 Recurrence rate of depression at 12 months</h6> <p>In the one trial comparing the combination of psychological therapies and antidepressant with psychological therapies (IPT) alone, combination was not superior to psychological therapies alone at 24 months (n = 50, RR 0.62, 96% CI 0.31 to 1.22; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD006727-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 6 Antidepressant/psychological therapies combination versus psychological therapies alone, outcome: 6.1 Recurrence." data-id="CD006727-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 6 Antidepressant/psychological therapies combination versus psychological therapies alone, outcome: 6.1 Recurrence. </p> </div> </div> </div> </section> <section id="CD006727-sec-0187"> <h6 class="title">6.2 Overall drop‐out rate at 12 months</h6> <p>We found no data on overall drop‐out rate at 12 months.</p> </section> </section> <section id="CD006727-sec-0188"> <h5 class="title">Secondary outcomes</h5> <section id="CD006727-sec-0189"> <h6 class="title">6.3 Relapse/recurrence rate of depression at other time points</h6> <p>In the one trial comparing the combination of psychological therapies and antidepressant with psychological therapies (IPT) alone, combination was superior to psychological therapies at 24 and 36 months (n = 50, RR 0.40, 95% CI 0.22 to 0.73; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>) (<a href="#CD006727-fig-0009">Figure 9</a>). </p> </section> <section id="CD006727-sec-0190"> <h6 class="title">6.4 Global clinical impression by the clinician</h6> <p>We found no data on global clinical impression by the clinician.</p> </section> <section id="CD006727-sec-0191"> <h6 class="title">6.5 Global clinical impression by the participant</h6> <p>We found no data on global clinical impression by the participant.</p> </section> <section id="CD006727-sec-0192"> <h6 class="title">6.6 Social functioning</h6> <p>We found no data on social functioning.</p> </section> <section id="CD006727-sec-0193"> <h6 class="title">6.7 Quality of life</h6> <p>We found no data on quality of life.</p> </section> <section id="CD006727-sec-0194"> <h6 class="title">6.8 Deaths</h6> <p>We found no data on deaths.</p> </section> <section id="CD006727-sec-0195"> <h6 class="title">6.9 Acceptability: overall drop‐out rate</h6> <p>One study yielded data to compare overall drop‐out rates (excluding deaths) at 36 months in the comparisons of antidepressant versus psychological therapies, psychological therapies versus placebo, and combination of antidepressant and placebo versus psychological therapies alone (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). There were no significant differences in any of these three comparisons. </p> </section> <section id="CD006727-sec-0196"> <h6 class="title">6.10 Acceptability: drop‐out rates due to drug‐related adverse effects</h6> <p>We found no data on drop‐out rates due to drug‐related adverse effects.</p> </section> </section> </section> <section id="CD006727-sec-0197"> <h4 class="title">Subgroup analyses</h4> <p>It was not possible to perform either of the a priori subgroup analyses as the required data were not reported. </p> </section> <section id="CD006727-sec-0198"> <h4 class="title">Sensitivity analyses</h4> <p>In the original review, we performed two a priori sensitivity analyses of recurrence rates in studies comparing antidepressant with placebo, on the basis of risk of bias in studies. In the first sensitivity analysis, we omitted the studies with unclear allocation concealment (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>; <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>; <a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>), which produced no change in significant findings. In the second sensitivity analysis, we omitted the one study with inadequate blinding of assessors (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>), which produced no change in significant findings. </p> <p>We performed three additional sensitivity analyses in the original review. In the first, we removed <a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a> (as an outlier) from the analysis of recurrence rates in studies comparing antidepressant with placebo; this did not affect the overall findings. In the second, we removed <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a> from the analysis (on the basis of younger age of participants); this did not affect the overall findings. In the third, we removed <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a> from the analysis of recurrence rates as the only study with a drop‐out rate of over 20%; this did not affect the overall findings. </p> <p>In this update, we performed further sensitivity analyses in response to feedback on the original review (received 20 April 2015). These analyses were to assess the effect of excluding drop‐outs from recurrence rates in <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>. The study authors used censoring of drop‐outs for their survival analysis whereas this review used the more conservative intention‐to‐treat for point‐in‐time analysis. We assumed that all drop‐outs had occurred during year one of follow‐up as the study authors were unable to provide exact timings of the drop‐outs. The sensitivity analyses produced no changes in significant findings except in comparison six (antidepressants/psychological therapies combination versus psychological therapies alone) where the combination of antidepressant and psychological therapy became superior to psychological therapy alone at 12 months, in the one study making this comparison. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006727-sec-0199" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006727-sec-0199"></div> <section id="CD006727-sec-0200"> <h3 class="title" id="CD006727-sec-0200">Summary of main results</h3> <p>This updated review was based on data from seven studies from which six comparisons were possible, involving 803 participants. Six of the studies compared continuation/maintenance antidepressant treatment with placebo. Only two studies involved psychological therapies. Both of these examined the effect of psychological therapies in combination with antidepressant medication compared with medication alone and one also compared the combination with both psychological therapies alone and placebo alone. Follow‐up intervals varied between the studies from six to 36 months. </p> <section id="CD006727-sec-0201"> <h4 class="title">Antidepressants versus placebo</h4> <p>Results for the primary outcomes are shown in <a href="./full#CD006727-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Six trials involving 708 participants compared continuation/maintenance antidepressant treatment with placebo, three trials using TCAs and three using SSRIs. Continuation/maintenance antidepressant medication reduced risk of recurrence after 12 months with an NNTB of 5. There was marked clinical heterogeneity in the studies and significant numbers of drop‐outs, but the direction of the effect was in favour of antidepressants in all trials. There was no statistically significant risk reduction for recurrence at 24 months when the analysis included all six studies. However, when data from the three trials of TCAs were analysed separately, there was a statistically significant reduction in recurrence risk with an NNTB of 5. It might be assumed that drop‐outs due to adverse effects would be greater with TCAs. However, there were no data that addressed this question as the only trials reporting drop‐outs due to adverse effects separately were the trials of SSRIs. </p> <p>In the one trial in which participants were followed up for 36 months, maintenance antidepressant medication reduced risk of recurrence after with an NNTB of 5 (<a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>). Participants in this trial were relatively young and cognitively unimpaired compared to participants in other trials. In this trial, in addition to outcome assessments, participants receiving placebo also attended medication clinics for physical assessment. For the purpose of this review, we considered this a placebo condition comparable to other studies in this comparison, but the medication clinic contact could be considered as an active treatment component. </p> </section> <section id="CD006727-sec-0202"> <h4 class="title">Antidepressants versus psychological therapies</h4> <p>Only one trial, involving 53 participants, compared an antidepressant (nortriptyline) with a psychological therapy (IPT). There was no significant difference in terms of recurrence of depression. Therefore, the available data were too limited to allow for any clear conclusion on the comparative efficacy of antidepressants and psychological therapies. There were no deaths among participants. </p> </section> <section id="CD006727-sec-0203"> <h4 class="title">Antidepressant/psychological therapies combination versus antidepressant</h4> <p>Two trials involving 98 participants compared a combination of continuation/maintenance antidepressant and psychological therapies with antidepressant alone. There was low heterogeneity between the two studies, despite their using different psychological treatments (group CBT and IPT). There was no significant difference in terms of recurrence of depression and no separate data on drop‐outs due to adverse effects. Only one trial reported drop‐outs due to deaths, with no difference between combination of continuation/maintenance antidepressant and psychological therapies and control. The available data were too limited to allow for any clear conclusions on comparative efficacy. </p> </section> <section id="CD006727-sec-0204"> <h4 class="title">Psychological therapies versus drug placebo</h4> <p>Only one trial compared IPT with drug placebo, in 54 participants. Overall, there was no significant difference in recurrence. There were no deaths recorded in either arm. They did not report drop‐outs due to adverse effects. </p> </section> <section id="CD006727-sec-0205"> <h4 class="title">Antidepressant/psychological therapies combination versus psychological therapies alone </h4> <p>Only one trial compared antidepressant/psychological therapies combination with psychological therapies alone (IPT) in 50 participants. There was a significant superiority of combination over psychological therapy alone at 24 and 36 months of follow‐up, but no significant difference at 12 months' follow‐up. They reported no deaths. They did not report drop‐outs due to adverse effects. Although this suggests that at two and three years the combination is more efficacious, it is possible that the finding in this one study has arisen by chance. </p> </section> <section id="CD006727-sec-0206"> <h4 class="title">Antidepressant/psychological therapies combination versus drug placebo</h4> <p>Only one trial compared antidepressant/psychological therapies combination with drug placebo in 54 participants. Overall, combination treatment was significantly superior to placebo at 12, 24, and 36 months' follow‐up with an NNTB of 2 at 12 months and 3 at 36 months. They reported no deaths and did not record drop‐outs due to adverse effects. </p> </section> </section> <section id="CD006727-sec-0207"> <h3 class="title" id="CD006727-sec-0207">Overall completeness and applicability of evidence</h3> <p>We identified only a small number of trials of antidepressant medication including two TCA drugs (nortriptyline and dothiepin) and three SSRIs (escitalopram, citalopram, and sertraline). Thus, evidence is lacking on other classes of antidepressant drug such as SNRIs, MAOIs, and mirtazapine (a NASSA), and other types of TCAs. </p> <p>We included only two trials involving psychological therapies so clearly further evaluation of psychological therapies is required, including IPT, CBT, and other psychological therapies such as psychodynamic, behavioural, and mindfulness‐based cognitive therapy. </p> <p>The follow‐up periods of the included trials varied. Only one trial followed up participants for as long as 36 months. </p> <p>Data on tolerability of treatments were lacking as most studies did not record drop‐out specifically due to adverse effects and deaths. </p> <p>For this review, the outcome used as a measure of efficacy was recurrence rates at six‐month intervals, that is, the raw number of new episodes detected at these intervals. However, in practice, the effect of treatment may be to delay the onset of episodes of depression by varying periods, which may still represent a clinically beneficial change. Some studies used survival analysis to capture this, but it is not reported in this review. It is also possible that treatment may reduce the severity of subsequent episodes (<a href="./references#CD006727-bbs2-0041" title="MontgomerySA , MontgomeryDB . Prophylactic treatment in recurrent unipolar depression. In: MontgomeryS , RouillonF editor(s). Long‐term Treatment of Depression. Chichester: Wiley, 1992:53‐79. ">Montgomery 1992</a>) which, again, may be of clinical benefit but is not addressed in this review. </p> </section> <section id="CD006727-sec-0208"> <h3 class="title" id="CD006727-sec-0208">Quality of the evidence</h3> <section id="CD006727-sec-0209"> <h4 class="title">Limitations in study design or execution (risk of bias)</h4> <p>All of the trials were randomised and double‐blind. However, only one trial specifically discusses whether blinding of psychological therapies was successful (<a href="./references#CD006727-bbs2-0006" title="WilkinsonP , AlderN , JuszczakE , MatthewsH , MerrittC , MontgomeryH , et al. A pilot randomised controlled trial of a brief cognitive behavioural group intervention to reduce recurrence rates in late life depression. International Journal of Geriatric Psychiatry2009;24:68‐75. ">Wilkinson 2009</a>). Allocation concealment was unclear in four of the seven studies. We judged two studies to have employed selective reporting of outcome data. </p> <p>The clinical effects of discontinuing antidepressants in placebo‐controlled maintenance trials could increase the apparent rates of relapse and recurrence in placebo arms thereby increasing in the apparent efficacy of antidepressants (<a href="./references#CD006727-bbs2-0041" title="MontgomerySA , MontgomeryDB . Prophylactic treatment in recurrent unipolar depression. In: MontgomeryS , RouillonF editor(s). Long‐term Treatment of Depression. Chichester: Wiley, 1992:53‐79. ">Montgomery 1992</a>). This would be most likely if careful dose titration is not employed. In the three studies in this review employing placebo antidepressant arms, procedures for antidepressant withdrawal were not clear. </p> </section> <section id="CD006727-sec-0210"> <h4 class="title">Inconsistency of results</h4> <p>Data were incomplete in places, for instance on the timing of drop‐outs in <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>; so, in this review, we assumed that all drop‐outs were in the first year of follow‐up. Drop‐out rates varied between studies from 0% (<a href="./references#CD006727-bbs2-0001" title="AlexopoulosGS , BarnettSM , YoungRC , KalayamB , KakumaT , GabrielleM , et al. Executive dysfunction and long‐term outcomes of geriatric depression. Archives of General Psychiatry2000;57:285‐90. ">Alexopoulos 2000</a>) to 22% (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). A sensitivity analysis omitting <a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a> did not affect overall the outcome. </p> </section> <section id="CD006727-sec-0211"> <h4 class="title">Indirectness of evidence</h4> <p>All studies directly addressed the main review question, that of prevention of relapse and recurrence in older people remitted from an episode of depression while taking antidepressant medication. </p> </section> <section id="CD006727-sec-0212"> <h4 class="title">Imprecision</h4> <p>There was a low number of studies in the review. For instance, only one study reported data on the primary outcome of overall drop‐outs at 12 months in antidepressant medication versus placebo. </p> </section> <section id="CD006727-sec-0213"> <h4 class="title">Publication bias</h4> <p>We produced a funnel plot to assess possible publication bias in the trials included in the main comparison (antidepressants versus placebo) (<a href="#CD006727-fig-0010">Figure 10</a>). The total number of studies (fewer than 10) means that application of a formal test of asymmetry was not appropriate. Simple visual inspection suggested possible publication bias with under‐reporting of small trials showing no effect; however, we identified no unpublished studies in communications with experts and known researchers in the field. </p> <div class="figure" id="CD006727-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence." data-id="CD006727-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence.</p> </div> </div> </div> </section> </section> <section id="CD006727-sec-0214"> <h3 class="title" id="CD006727-sec-0214">Potential biases in the review process</h3> <p>The search in this review was based on the Cochrane Common Mental Disorders (CCMD) Controlled Register of Trials (which is largely composed of searches of already published literature), as well as the review authors' own searches. Therefore, it is possible that there are unpublished trials that we are not aware of although it is expected that these would have been identified through the communications that were made with experts and researchers in the field. </p> <p>It is clear that there was significant between‐trial clinical heterogeneity in this review. For instance, participants in some trials were more cognitively impaired, some had greater physical morbidity, some were older on average, and some had been treated as inpatients. Some trials used more stringent criteria for remission before randomisation, while run‐in and dose‐tapering periods varied between trials. </p> <p>Another potential source of heterogeneity was the range of psychological treatments included in the review. However, only one analysis combined results from different psychological treatments (combination versus antidepressants at 12 months) and heterogeneity was low. This potential source of heterogeneity might be addressed in future versions of this review by categorising psychological treatments, for instance, including problem‐solving therapies in CBT. </p> <p>For the purposes of this review, we treated medication clinic and placebo in <a href="./references#CD006727-bbs2-0008" title="ReynoldsCFIII , PerelJM , FrankE , CornesC , MillerMD , HouckPR , et al. Three‐year outcomes of maintenance nortriptyline treatment in late‐life depression: a study of two fixed plasma levels. American Journal of Psychiatry1999;156(8):1177‐81. ">Reynolds 1999b</a> as a pure placebo condition. Face‐to‐face clinician contact in the medication clinic could be regarded as making this an active intervention. However, we believe this to be an adequate comparison as it helps to control for the effect of clinician contact in the parallel psychological treatment condition, IPT. </p> <p>Recruiting older people to clinical research trials can be difficult due to the burden of research, and communication difficulties, etc. (<a href="./references#CD006727-bbs2-0021" title="ForsterE , JonesL , SaxtonJM , FlowerDJ , FouldsG , PowersHJ , et al. Recruiting older people to a randomised controlled dietary intervention trial ‐ how hard can it be?. BMC Medical Research Methodology2010;10:17. [DOI: 10.1186/1471‐2288‐10‐17] ">Forster 2010</a>). Therefore, selection bias in studies may have arisen in this review if the participants who were successfully recruited were not representative of people in the general clinical population. </p> <p>When study sponsors have an interest in the outcome of a study, there is a risk of bias in the reporting of results. This review did not include data on funding source of studies so the potential for funding bias was not assessed. </p> <p>Despite the differences between trials, we believe that meta‐analysis was appropriate. We addressed heterogeneity using the random‐effects model in meta‐analysis as this allows for clinical heterogeneity between trial populations. The random‐effects model does emphasise the results from smaller trials, which are often those most prone to bias. However, when we performed a fixed‐effect analysis for the main finding of the review (reduced recurrence rates for antidepressant medication versus placebo at 12 months), there was no difference in the overall relative risks calculated. We also examined the effects of clinical heterogeneity using sensitivity analysis with change in overall findings. </p> <p>This review used a point‐in‐time dichotomous outcome (recurrence rate from intention‐to‐treat analyses) for the main meta‐analysis. While we believe this to be the most appropriate method for the review, it is acknowledged that it may produce more conservative estimates of treatment effect than survival analysis and use of hazard ratios (<a href="./references#CD006727-bbs2-0038" title="MichielsS , PiedboisP , BurdettS . Meta‐analysis when only the median survival times are known: a comparison with individual patient data results. International Journal of Technology Assessment in Health Care2005;21(1):119‐25. ">Michiels 2005</a>). </p> <p>Some of the analyses in this review used very small numbers of studies and may not have had sufficient statistical power to detect small effect sizes. However, we did not perform a power calculation to assess this. </p> <p>The effects of antidepressant discontinuation can be misinterpreted as symptoms of depression recurrence. Therefore, there is an argument for excluding recurrences in the first four weeks of randomisation from analysis, although we did not apply this strategy in this review. </p> </section> <section id="CD006727-sec-0215"> <h3 class="title" id="CD006727-sec-0215">Agreements and disagreements with other studies or reviews</h3> <p>In one review of RCTs of continuation/maintenance antidepressant treatment with adults of all ages, five of 31 included trials were with older adults, although there was no separate analysis of these trials (<a href="./references#CD006727-bbs2-0026" title="GeddesJ , CarneyS , DaviesC , FurukawaT , KupferD , FrankE , et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet2003;361:653‐61. ">Geddes 2003</a>). Continuing treatment with antidepressants reduced the odds of relapse by 70%, compared with a reduction in this review (specifically with adults aged 60 years and over) of 52% at final outcome. </p> <p>Kok et al. evaluated the efficacy of antidepressant treatment in the prevention of recurrence of depression in older people through a systematic review of literature and meta‐analysis of seven RCTs (<a href="./references#CD006727-bbs2-0033" title="KokRM , HeerenTJ , NolenWA . Continuing treatment of depression in the elderly: a systematic review and meta‐analysis of double‐blinded randomized controlled trials with antidepressants. American Journal of Geriatric Psychiatry2011;19(3):249‐55. ">Kok 2011</a>). We excluded two trials that were included in Kok's meta‐analysis from this review: the first because it included participants aged 55 years and above with no separate analysis of data from participants aged 60 years and above (<a href="./references#CD006727-bbs2-0027" title="GeorgotasA , McCueRE , CooperTB . A placebo‐controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Archives of General Psychiatry1989;46:783‐6. ">Georgotas 1989</a>); and the second because participants were allowed to continue augmentation treatments after randomisation (<a href="./references#CD006727-bbs2-0009" title="CarreiraK , MillerMD , FrankE , HouckPR , MorseJQ , DewMA , et al. A controlled evaluation of monthly maintenance Interpersonal psychotherapy in late‐life depression with varying levels of cognitive function. International Journal of Geriatric Psychiatry2008;23:1110‐3. DombrovskiAY , LenzeEJ , DewMA , MulsantBH , PollockBG , HouckPR , et al. Maintenance treatment for old‐age depression preserves health‐related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Journal of the American Geriatrics Society2007;55(9):1325‐32. ReynoldsCF , DewMA , PollockBG , MulsantBH , FrankE , MillerMD , et al. Maintenance treatment of major depression in old age. New England Journal of Medicine2006;354:1130‐8. ">Reynolds 2006</a>). We included the other six trials from Kok's review in the equivalent comparison in this review. There were also some methodological differences in Kok's meta‐analysis: only final follow‐up data from six to 36 months were pooled, with no breakdown by follow‐up interval; drop‐outs from treatment were not included in recurrences/relapses; and in extracting data from <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>, Kok et al. combined data from participants receiving interpersonal psychological therapies with participants in drug placebo arms. However, despite the differences between the reviews, Kok et al. reported a comparable NNTB of 3.6 (to be rounded to 4) to prevent one additional recurrence/relapse, and no difference in tolerability between TCAs and SSRIs. </p> <p>Frederick et al. reported an expert‐panel informed narrative review of treatments for late‐life depression, but this did not include continuation or maintenance treatments (<a href="./references#CD006727-bbs2-0023" title="FrederickJT , SteinmanLE , ProhaskaT , SatarianoWA , BruceM , BryantL , et al for the Late Life Depression Special Interest Project Panelists. Community‐based treatment of late life depression. An expert panel‐informed literature review. American Journal of Preventive Medicine2007;33(3):222‐49. ">Frederick 2007</a>). </p> <p>The review authors are not aware of any other reviews of trials of continuation/maintenance psychological therapies in late‐life depression. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006727-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram (including studies in previous review version)." data-id="CD006727-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram (including studies in previous review version).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006727-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006727-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence." data-id="CD006727-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.6 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Antidepressant versus placebo, outcome: 1.6 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 7 Antidepressant/psychological therapies combination versus drug placebo, outcome: 7.1 Recurrence." data-id="CD006727-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 7 Antidepressant/psychological therapies combination versus drug placebo, outcome: 7.1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Antidepressant versus psychological therapies, outcome: 2.1 Recurrence." data-id="CD006727-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antidepressant versus psychological therapies, outcome: 2.1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Antidepressant/psychological therapies combination versus antidepressant alone, outcome: 5.1 Recurrence." data-id="CD006727-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Antidepressant/psychological therapies combination versus antidepressant alone, outcome: 5.1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 6 Antidepressant/psychological therapies combination versus psychological therapies alone, outcome: 6.1 Recurrence." data-id="CD006727-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 6 Antidepressant/psychological therapies combination versus psychological therapies alone, outcome: 6.1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence." data-id="CD006727-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antidepressant versus placebo, outcome: 1.2 Recurrence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 1 Recurrence." data-id="CD006727-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 1 Recurrence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 2 Recurrence at 12 months (fixed‐effect)." data-id="CD006727-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 2 Recurrence at 12 months (fixed‐effect).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 3 Recurrence at 24 months (studies of tricyclic antidepressants only)." data-id="CD006727-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 3 Recurrence at 24 months (studies of tricyclic antidepressants only). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 4 Reduction in symptom severity." data-id="CD006727-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 4 Reduction in symptom severity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 5 Death." data-id="CD006727-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 5 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 6 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 6 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antidepressant versus placebo, Outcome 7 Drop‐outs due to adverse effects." data-id="CD006727-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antidepressant versus placebo, Outcome 7 Drop‐outs due to adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Psychological therapies versus drug placebo, Outcome 1 Recurrence." data-id="CD006727-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Psychological therapies versus drug placebo, Outcome 1 Recurrence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Psychological therapies versus drug placebo, Outcome 2 Deaths." data-id="CD006727-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Psychological therapies versus drug placebo, Outcome 2 Deaths.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Psychological therapies versus drug placebo, Outcome 3 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Psychological therapies versus drug placebo, Outcome 3 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-003-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antidepressant/psychological therapies combination versus drug placebo, Outcome 1 Recurrence." data-id="CD006727-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Antidepressant/psychological therapies combination versus drug placebo, Outcome 1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antidepressant/psychological therapies combination versus drug placebo, Outcome 2 Death." data-id="CD006727-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Antidepressant/psychological therapies combination versus drug placebo, Outcome 2 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antidepressant/psychological therapies combination versus drug placebo, Outcome 3 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Antidepressant/psychological therapies combination versus drug placebo, Outcome 3 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antidepressant versus psychological therapies, Outcome 1 Recurrence." data-id="CD006727-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Antidepressant versus psychological therapies, Outcome 1 Recurrence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antidepressant versus psychological therapies, Outcome 2 Death." data-id="CD006727-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Antidepressant versus psychological therapies, Outcome 2 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antidepressant versus psychological therapies, Outcome 3 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Antidepressant versus psychological therapies, Outcome 3 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-005-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Antidepressant/psychological therapies combination versus antidepressant alone, Outcome 1 Recurrence." data-id="CD006727-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Antidepressant/psychological therapies combination versus antidepressant alone, Outcome 1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Antidepressant/psychological therapies combination versus antidepressant alone, Outcome 2 Death." data-id="CD006727-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Antidepressant/psychological therapies combination versus antidepressant alone, Outcome 2 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Antidepressant/psychological therapies combination versus antidepressant alone, Outcome 3 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Antidepressant/psychological therapies combination versus antidepressant alone, Outcome 3 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-006-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Antidepressant/psychological therapies combination versus psychological therapies alone, Outcome 1 Recurrence." data-id="CD006727-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Antidepressant/psychological therapies combination versus psychological therapies alone, Outcome 1 Recurrence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Antidepressant/psychological therapies combination versus psychological therapies alone, Outcome 2 Deaths." data-id="CD006727-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Antidepressant/psychological therapies combination versus psychological therapies alone, Outcome 2 Deaths. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006727-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/urn:x-wiley:14651858:media:CD006727:CD006727-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_t/tCD006727-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Antidepressant/psychological therapies combination versus psychological therapies alone, Outcome 3 Overall drop‐out rates (excluding deaths)." data-id="CD006727-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Antidepressant/psychological therapies combination versus psychological therapies alone, Outcome 3 Overall drop‐out rates (excluding deaths). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/media/CDSR/CD006727/image_n/nCD006727-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006727-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antidepressant medication compared with placebo at 12 months' follow‐up</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Antidepressant medication compared with placebo at 12 months' follow‐up</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> older people in remission from depression<br/> <b>Setting:</b> mixed<br/> <b>Intervention:</b> antidepressant<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antidepressant</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Recurrence at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.67<br/> (0.55 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>247<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2 trials used TCAs (<a href="./references#CD006727-bbs2-0004" title="Old Age Depression Interest Group. How long should the elderly take antidepressants? A double‐blind placebo‐controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry1993;162:175‐82. ">OADIG 1993</a>; <a href="./references#CD006727-bbs2-0005" title="DewMA , ReynoldsCF3rd , MulsantB , FrankE , HouckPR , MazumdarS , et al. Initial recovery patterns may predict which maintenance therapies for depression will keep older adults well. Journal of Affective Disorders2001;65(2):155‐66. LenzeEJ , DewMA , MazumdarS , BegleyAE , CornesC , MillerMD , et al. Combined pharmacotherapy and psychotherapy in maintenance treatment of late‐life depression: effects on social adjustment, perception of health, and quality of life. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco. 2001. MillerMD , FrankE , CornesC , HouckPR , ReynoldsCF3rd . The value of maintenance interpersonal psychotherapy (IPT) in older adults with different IPT foci. American Journal of Geriatric Psychiatry2003;11(1):97‐102. ReynoldsCF3rd , FrankE , DewMA , HouckPR , MillerM , MazumdarS , et al. Treatment of 70(+)‐year‐olds with recurrent major depression. Excellent short‐term but brittle long‐term response. American Journal of Geriatric Psychiatry1999;7(1):64‐9. ReynoldsCFIII , FrankE , PerelJM , ImberSD , CornesC , MillerMD , et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years. JAMA1999;281(1):39‐45. ">Reynolds 1999a</a>); 1 used an SSRI (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). Trials varied in setting, mean age, cut‐off for remission, and length of remission before randomisation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>730 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>489 per 1000<br/> (402 to 599) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>759 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>508 per 1000<br/> (417 to 622) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Overall drop‐out rates (excluding deaths) at 12 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.48<br/> (0.75 to 2.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>121<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Only 1 trial reporting drop‐outs at 12 months (<a href="./references#CD006727-bbs2-0003" title="Bent‐HansenJ , LundeM , KlysnerR , AndersenM , TanghojP , SolstadK , et al. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry2003;36(6):313‐6. KlysnerR , Bent‐HansenJ , HansenHL , LundeM , PleidrupE , PoulsenDL , et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo‐controlled study of maintenance therapy. British Journal of Psychiatry2002;181:29‐35. KlysnerR , PledrupE , HansenHL , Loldrup PoulsenD , HansenJB , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23‐26; San Francisco, CA. 2001. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , LoldrupPD , LundeM , et al. The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. International Journal of Neuropsychopharmacology2000;3(Suppl 3):211. KlysnerR , PleidrupE , HansenHL , Bent‐HansenJ , Loldrup PoulsenD , Hopfner PetersenHE . The effectiveness of citalopram in the prevention of depression recurrence in elderly patients. 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13‐18; Chicago, IL. 2000:NR472. ">Klysner 2002</a>). <a href="./references#CD006727-bbs2-0008" title="ReynoldsCFIII , PerelJM , FrankE , CornesC , MillerMD , HouckPR , et al. Three‐year outcomes of maintenance nortriptyline treatment in late‐life depression: a study of two fixed plasma levels. American Journal of Psychiatry1999;156(8):1177‐81. ">Reynolds 1999b</a> reported drop‐outs but not timing </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>267 per 1000<br/> (135 to 527) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>267 per 1000<br/> (135 to 526) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>SSRI:</b> selective serotonin reuptake inhibitor; <b>TCA:</b> tricyclic antidepressant. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Downgraded one point for imprecision (only three studies) and one point for risk of bias since allocation concealment and blinding were unclear for two of the studies and study protocols were not available for all three studies. </p> <p>2. Downgraded two points due to imprecision (only one study; wide confidence intervals).</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antidepressant medication compared with placebo at 12 months' follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/full#CD006727-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006727-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antidepressant versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Recurrence at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>487</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.32, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrence at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.55, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Recurrence at 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.49, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Recurrence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>282</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.61, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Recurrence at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.45, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Recurrence at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.48, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence at 12 months (fixed‐effect) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.54, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recurrence at 24 months (studies of tricyclic antidepressants only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.50, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Reduction in symptom severity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 CGI‐Severity at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.04, ‐0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 CGI‐Intensity at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.77 [‐1.06, ‐0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Deaths at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Deaths at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Deaths at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.21, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Deaths at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Deaths at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>475</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.21, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Overall drop‐out rates (excluding deaths) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Drop‐outs at six months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.35, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Drop‐outs at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.75, 2.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Drop‐outs at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.52, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Drop‐outs at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.31 [0.52, 165.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Drop‐outs due to adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Drop‐outs at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.17, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Drop‐outs at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.28, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Drop‐outs at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.27, 1.84]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antidepressant versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006727-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Psychological therapies versus drug placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Recurrence at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.45, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.75, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Recurrence at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Deaths at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Deaths at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Deaths at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Deaths at final outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall drop‐out rates (excluding deaths) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.38 [0.59, 183.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Drop‐outs at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.38 [0.59, 183.92]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Psychological therapies versus drug placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006727-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Antidepressant/psychological therapies combination versus drug placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Recurrence at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.23, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.21, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Recurrence at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.20, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Recurrence at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.20, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Death at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Death at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Death at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Death at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall drop‐out rates (excluding deaths) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.08 [0.44, 149.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Antidepressant/psychological therapies combination versus drug placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006727-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antidepressant versus psychological therapies</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Recurrence at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.47, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.49, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Recurrence at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.49, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Recurrence at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.49, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Deaths at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Deaths at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Deaths at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Deaths at final outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall drop‐out rates (excluding deaths) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.25, 3.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Drop‐outs at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.25, 3.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antidepressant versus psychological therapies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006727-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Antidepressant/psychological therapies combination versus antidepressant alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Recurrence at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.18, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrence at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.36, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Recurrence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.29, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Recurrence at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.29, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Recurrence at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.34, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Deaths at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 15.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Deaths at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 15.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Deaths at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Deaths at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Deaths at final outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.07, 15.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall drop‐out rates (excluding deaths) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Drop‐outs at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.20, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Drop‐outs at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.20, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Drop‐outs at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.21, 3.39]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Antidepressant/psychological therapies combination versus antidepressant alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006727-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Antidepressant/psychological therapies combination versus psychological therapies alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Recurrence at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.31, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.22, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Recurrence at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.22, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Recurrence at final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.22, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Deaths at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Deaths at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Deaths at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Deaths at final outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Overall drop‐out rates (excluding deaths) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.08 [0.44, 149.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Drop‐outs at 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.08 [0.44, 149.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Antidepressant/psychological therapies combination versus psychological therapies alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006727.pub3/references#CD006727-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006727.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006727-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006727-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006727-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD006727-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD006727-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006727-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD006727-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD006727-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006727-note-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006727-note-0012">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006727\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006727\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006727\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006727\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006727\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006727.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006727.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006727.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006727.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006727.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714249807"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006727.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714249811"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006727.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6a12b9cdf3cd',t:'MTc0MDcxNDI1MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 